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Chair: Dr. Jeff McKinnon 
Major Department: Biology 
 Chytridiomycosis is an amphibian disease caused by the fungal pathogen 
Batrachochytrium dendrobatidis (Bd;Longcore et al. 1999). This disease has been identified by 
the Amphibian Conservation Action Plan as one of the main causal agents of worldwide 
amphibian declines and extinctions, and as the worst infectious disease ever recorded among 
vertebrates. Prior to this investigation, little was known about the prevalence of Bd across Peru, a 
country renowned for its high amphibian diversity and endemism.  Here, I report the results of a 
sampling effort for Bd prevalence from the dry seasons of 2007 and 2008, which showed that 
among site Bd prevalence ranged from 0 to 25%. In this study, Bd was detected in 11 of 983 
individuals sampled, and in nine out of 38 sites ranging in altitude from 96-3240 meters. I also 
discuss the implications of these results and suggest directions for further studies of Bd in Peru in 
order to better understand the ecology of this devastating disease and its effects on this 
biodiverse region. 
 In addition to investigating the prevalence of Bd throughout Peru, I also was interested in 
comparing and developing methods for the detection of Bd. Since the discovery of Bd, several 
methods have been utilized for detection; among these PCR from skin swabs is accepted as the 
best method due to its high sensitivity, non-invasiveness and ease of use. However, since PCR is 
a chemical reaction that requires a specific DNA template to proceed, this method relies upon 
both the presence of non-degraded DNA template and reaction components that do not inhibit 
the process. Here I present the results of experimental comparisons of techniques for sample 
preservation, DNA extraction, and PCR. My results show that the most advantageous techniques 
for a Bd-field study are swab preservation in 95% ethanol, DNA extraction with DNeasy, and an 
end-point PCR disease assay with BSA and Amplitaq Gold. I also recommend the use of 
PowerClean for samples with suspected PCR inhibitors. My hope is that these techniques will 
promote increases in sample collection and laboratory analyses for Bd research in developing 
countries where such activities are drastically needed. 
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CHAPTER 1: BACKGROUND INFORMATION 
What is Bd? 
 The chytrid fungus, Batrachochytrium dendrobatidis (hereafter, Bd), has emerged as a 
novel pathogen afflicting amphibian populations worldwide (Fisher et al. 2009).  It has been 
identified as a major factor driving amphibian declines and extinctions, making it one of the most 
destructive infectious diseases ever identified (Gascon et al. 2007).  Declines and extinctions 
have been recorded from many different countries including: the United States (Briggs et al. 
2005), Europe (Bosch and Martinez-Solano 2006), Central and South America (Lips et al. 2008) 
and Australia (Berger et al. 1998).  The IUCN recently reported that 30 percent of all amphibians 
are at risk of extinction (Vié et al. 2009), making this the most critically endangered group of 
vertebrates in the world.  In many cases, these declines are occurring in places that are not 
obviously affected by factors typically associated with decline, such as pollution and 
deforestation.  Some sort of infectious agent is implicated in these cases, and the main culprit 
appears to be Batrachochytrium dendrobatidis (Bd), which causes the often lethal disease 
chytridiomycosis.   
 Chytridiomycosis was identified first by Berger et al. (1998) and then described by 
Longcore et al. (1999).  Extensive population sampling has demonstrated that this disease can 
and does cause both dramatic declines of entire amphibian communities and local population 
extinctions (e.g., Lips et al. 2006).  However, there are examples where Bd has infected 
populations, but dramatic declines have not occurred (e.g., Briggs et al. 2005, Puschendorf et al. 
2006).  Currently, it is unclear whether differences in the impact of the chytrid are caused by 
variation in environmental conditions (Kriger et al. 2007), ecological factors (Lips et al. 2003), 
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host immunity (Woodhams et al. 2006), differences among strains (Berger et al. 2005), or some 
combination of these factors. 
 Bd belongs to the basal fungal lineage Chytridiomycota which is comprised of mostly 
soil dwelling or aquatic detritivores (James et al. 2006). Bd is the only member of 
Chytridiomycota known to parasitize vertebrates (Longcore et al. 1999). Chytridiomycota is 
characterized by the presence of a mobile, flagellated zoospore stage (Longcore et al 1999). In 
culture, Bd can be grown easily on tryptone media and grows best at 17–25°C (Piotrowski et al. 
2004). Other important abiotic conditions for growth in culture include humidity and pH. The 
life cycle begins with a motile zoospore which eventually encysts in the keratinized region of the 
host’s epidermis, where it then develops into a zoosporangium (Piotrowski et al. 2004).  Each 
zoospore produces a single zoosporangium that later divides mitotically to produce more 
zoospores (Berger et al. 2005b).  After maturation, new zoospores are released into the 
environment via a discharge tube (Berger et al. 2005b). The entire life cycle in culture lasts four 
to five days at 22°C (Piotrowski et al. 2004). In tadpoles, Bd is restricted to keratinized 
mouthparts (Berger et al. 2000) and does not normally induce mortality (Marentelli et al. 2004, 
but see Blaustein et al. 2005). In juveniles and adults, Bd is dispersed across the epidermis, but 
tends to be especially concentrated in the feet and pelvic region (Berger et al. 2005c). In these 
individuals, the pathogen disrupts active electron transport across the skin (especially sodium) 
causing eventual death due to altered homeostasis (Voyles et al. 2009). Although the mechanism 
by which Bd disrupts electrolyte transport across the skin is unknown, Voyles et al. (2009) 
demonstrated that electrolyte transport across the skin was inhibited by as much as 50% in Bd 
infected individuals, which contributed to a 20-50% reduction in plasma potassium and sodium 
ion concentrations and lead to ultimate death by asystolic cardiac arrest.   
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 Investigations in the field also have shown that a variety of environmental factors 
influence Bd virulence. Some of these include: altitude (Woodhams and Alford 2005, Brem and 
Lips 2008), temperature (Woodhams and Alford 2005), precipitation (Ron 2005, Fisher et al. 
2009), and habitat type (Kriger and Hero 2007, Brem and Lips 2008). Additionally, various 
ecological and evolutionary factors associated with the host have been shown to dramatically 
affect pathogenicity:  lifetime aquatic index (i.e., a measure of time spent associated with water, 
Lips et al. 2003), riparian reproduction (Kriger and Hero 2007, Brem and Lips 2008), endemicity 
(Bielby et al. 2008, Smith et al. 2009), and evolutionary history (Corey and Waite 2008). Using 
Bd distribution data and many of the factors listed above, ecological niche modeling has been 
utilized in various ways to make broadscale predictions concerning the localities that are highly 
susceptible to Bd-related declines (Ron 2005, Bielby et al. 2008, Rödder et al. 2009). Many of 
these models predict that amphibians living tropical and subtropical montane habitats are the 
most vulnerable to chytridiomycosis declines.  
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Origin of Bd 
 There is substantial debate concerning the origin of Bd as a lethal pathogen.  Some 
researchers have proposed that Bd is a recently emerged pathogen that is sweeping through 
amphibian populations (“novel pathogen hypothesis” of Berger et al. 1998, Skerratt et al. 2007).  
A variety of evidence supports this hypothesis.  For example, in both Central America and 
Australia, researchers have monitored areas predicted to be affected by an advancing wave of 
chytrid infection (Berger et al. 1998, Lips et al. 2006).  Samples taken during early monitoring 
did not reveal the presence of the chytrid.  This was followed by a wave of infections affecting 
virtually all amphibians, resulting in massive declines and local extinctions.  At the genetic level, 
Morehouse et al. (2003) found extremely low levels of genetic variation among Bd isolates from 
Africa, Australia, North America and Panama, further supporting the hypothesis that Bd is novel, 
emerging pathogen.  Several subsequent surveys have found similar results (Morgan et al. 2007, 
James et al. 2009).  Although there have been many long-term studies of amphibian populations 
since the 1900’s, there were no records of mass mortality caused by disease until the late 1970’s 
when the first Bd epidemics were reported (Barinaga 1990).  However, inspections of museum 
specimens have detected Bd in skin cross-sections from as long ago as 1902 in Japan (Goka et al. 
2006) and 1938 in Africa (Weldon et al. 2004).  It has been proposed that a novel, pathogenic 
form of the chytrid was spread globally through the exportation of a host species, the African 
Clawed Frog (Xenopus laevis), in the 1960’s (Weldon et al. 2004).  This species was exported 
across the world in massive quantities for use in human pregnancy tests. Recently, a comparison 
of 20 Bd genomes from multiple continents found three distinct lineages of the fungus which 
differ in virulence and other morphological traits (Farrer et al. 2011). They provide evidence that 
the hypervirulent lineage observed worldwide may have arisen from a recombination event from 
5 
 
two less virulent lineages which likely came into contact from the global trade of amphibians 
(Farrer et al. 2011).  
 In contrast to the novel pathogen hypothesis, the “endemic pathogen hypothesis” 
(Rachowicz et al. 2005, Pounds et al. 2006) proposes that Bd was present in the environment (in 
a saprobic or sporitic form) before the outbreaks, but that some kind of environmental change 
caused the fungus to become pathogenic.  There is some evidence for an inactive, non-
pathogenic form of Bd (Di Rosa et al. 2007), but this has yet to be verified  Evidence of 
correlations between warming trends and Bd-related declines also are consistent with the 
endemic pathogen hypothesis (e.g., Pounds et al. 2006, Alford et al. 2007).  
 Since the discovery of Bd over a decade ago, considerable progress has been made to 
ascertain the mechanisms of global dispersal and the origin of this pathogen. The research of 
Morehouse et al. (2003), Morgan et al. (2007), James et al (2009), and most recently Farrer et al. 
(2011) has been especially insightful at contributing to the understanding of the origin of this 
disease. Yet, many important questions remain to be answered--most pressing the identification 
of the geographic origin of Bd. Here, I try to address a small part of this enigma by investigating 
the prevalence of this disease in a biodiverse and understudied region. In the future, I plan to use 
the many of the skills and samples obtained from this research to continue to address this 
question using phylogeographic methods.   
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Bd Worldwide Distribution 
 Bd is has been found on all continents that amphibians are known to occur (Fisher et al. 
2009). Despite this, sampling for Bd has been somewhat biased in that the majority of studies 
that have been conducted to date have taken place in developed countries (i.e., United States, 
Europe, Australia, Global Bd-Mapping Project 2012). Unfortunately, amphibian diversity and 
endemism often are highest in developing regions (Figure 1, IUCN Red List 2008) meaning that 
a high proportion of global amphibian diversity may be threatened by Bd and we may not even 
be aware of it. The scarcity of Bd studies in developing countries likely occurs because of a 
combination of factors including the general lack of funding, absence of molecular facilities, 
shortage of trained investigators, and ease of access to sampling sites. Of these, the inability for 
researchers to perform the PCR diagnostic procedure ‘in-house’ is probably the biggest 
contributor to the scarcity of research in these countries. This is unfortunate due to the high value 
of information on Bd prevalence from these regions. and because the PCR disease assay can be 
performed by individuals after minimal training investments and moderate monetary investment. 
A major component of my dissertation work has been to develop a Bd PCR assay is not only 
reliable, but that can be performed by individuals with a minimal training investment and at 
facilities with only a moderate monetary investment. I will discuss the development and 
substantiation of this assay in Chapters 3 and 4 of this document.  
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Bd in South America and Peru 
 Our knowledge of the history of Bd in South America begins in Ecuador where it was 
first detected in 1980 (Ron and Merino-Viteri 2000). Since then, Bd has been detected in most 
South American countries where samples have been analysed (Carnaval et al. 2006). Intensive 
monitoring efforts in Ecuador have documented the effects of Bd infection on montane endemic 
populations of frogs in the genus Atelopus, where it has caused widespread extinction at both the 
population and species level (Ron and Merino-Vitteri 2000, La Marca et al. 2005). Other 
Ecuadorian species also have been affected, as documented by intensive monitoring at seven 
different sites (Bustamante et al. 2005).  
 In Brazil, the first record of Bd (1981, Carnaval et al. 2006) comes from the Atlantic 
Forest region. Interestingly, this record coincides with several historical reports in this area of 
unexplained declines (Carnaval et al. 2006). Bd has been well studied in this region; to date, 21 
species have been found to be infected (Carnaval et al. 2006, Toledo et al. 2006). Other regions 
throughout the country remain under-sampled including areas that have been predicted to be 
suitable for disease establishment by niche modelling (Ron et al. 2005) such as the Cerrado and 
Pantanal regions.  
 In contrast to Ecuador and Brazil, comparatively little effort has been spent monitoring 
amphibian populations for the effect of Bd infection in Peru and other South American countries 
(Lips et al. 2005). Yet, Ron et al. (2005) identified the eastern slopes of the Andes in Peru and 
Bolivia (through niche modeling) as one of the new world regions with highest suitability for Bd 
establishment. The cordilleras that make up the transition zone between the Andes Mountains 
and Amazonian lowlands are one of the most species rich regions on earth (Fjeldsa and Rahbek 
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2006). Species richness and regional endemicity are particularly high for amphibians in this area 
(Duellman 1982). In fact, the area is unrivalled in amphibian biodiversity (Duellman 1999). Peru 
is situated along the majority of the Andean massif, with vast tracts of transition zone cordilleras 
spanning the gap between the Andean highlands and the Amazonian lowlands. Such habitat 
variation promotes biodiversity and allows Peru to be ranked fourth in worldwide amphibian 
biodiversity survey (Vié et al. 2009). The emergence of Bd in this region potentially poses a 
grave risk to this biodiversity.  
 The first record of Bd in Peru came from several dead Atelopus patazensis collected in 
1999 (Venegas et al. 2008) this species is currently listed as critically endangered by the IUCN 
due to the combined effects of Bd and water pollution (IUCN 2011). Reliable data are not 
available on the status of other Atelopus species in Peru (Venegas et al. 2008, von May et al. 
2008), though many are known to be declining in other countries (La Marca et al. 2005). 
Population surveys for A. pulcher in northern Peru have not detected any adults in localities 
where they were once abundant; one of the last individuals seen was found dead and later tested 
Bd-positive (Lötters et al. 2005). Another study in northern Peru, failed to detect Bd in 23 
individuals tested using histopathological analysis (Enciso et al. 2008).  In southern Peru, the 
first record of Bd came from three of four Telmatobius marmoratus collected in 2002 in the 
Cordillera Vilcanota (Seimon et al. 2005). A later study in this region reported a range expansion 
of Bd to the highest altitude yet recorded (5348 m). Seimon et al. (2007) posit that this expansion 
may be due to the recent deglaciation and subsequent host population expansion in the region. 
Additionally, it appears Bd may be contributing to declines in T. marmoratus, one of the two 
host species investigated in this study (Seimon et al. 2007). Most recently, Catenazzi et al. 
(2011) discovered dramatic declines in montane amphibian species richness and abundance in 
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southern Peru between surveys from 1999 and 2008-2009. They attributed these declines to 
chytridiomycosis rather than habitat loss because Bd is widespread in the region and declines 
occurred within the well-protected zone of Manu National Park (Catenazzi et al. 2011).  
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Detection of Bd  
 Since the discovery of Bd in 1998 (Berger et al. 1998), several methods have been 
utilized for its detection from amphibian hosts: these methods include clinical symptoms and 
mortality, histology, end-point Polymerase Chain Reaction (PCR), and quantitative PCR (qPCR). 
PCR is a technique that uses specific oligonucleotide primers to amplify a targeted DNA 
molecule across many orders of magnitude. Mechanistically, end-point PCR differs from qPCR 
in that the end results are determined by scoring for the presence of bands using gel 
electrophoresis, whereas, qPCR utilizes an apparatus that detects increases in the fluorescence of 
a reporter dye, which either intercalates to double stranded DNA or hybridizes to specific 
complementary DNA targets. Measuring fluorescence to detect targeted DNA with qPCR also 
has the added advantage of allowing quantitation of accumulating product, which can be used 
estimate original sample concentration. In contrast, end-point PCR cannot reliably estimate 
sample DNA concentration and is normally only used for detection purposes or DNA sequencing 
studies.  
 Today PCR of amphibian skin swabs (especially qPCR) is the most widely used method 
for Bd detection (Hyatt et al. 2007). Both end-point and quantitative PCR have many advantages 
over previous methods. First, PCR methods are far more sensitive (likely to diagnose the disease 
when present at low levels) than other published methods, and this is especially so within the 
early stages of Bd infection when diagnosis by clinical symptoms or histology is limited if not 
impossible (Boyle et al. 2004, Kriger et al. 2006b). This is because most amphibians do not 
display clinical symptoms until the latter stages of infection (i.e., around 10-21 days, Rosenblum 
et al. 2009). In addition, the primary infection may be patchy or limited to one body region 
making detection with histology a game of chance (Boyle et al. 2004, Kriger et al. 2006). PCR is 
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advantageous here in both cases, because it is able to detect extremely low levels of the disease 
(i.e., 0.1 zoospore equivalents, Boyle et al. 2004), which allows diagnosis as early as day three 
(Rosenblum et al. 2009). PCR of skin swabs also has the added advantage of covering the entire 
surface of the animal thus increasing likelihood of detection, which is advantageous the infection 
distribution is patchy. Secondly, PCR has greater specificity (ability to correctly diagnosis the 
disease) than other methods (Hyatt et al. 2007). This is especially true when compared to 
diagnoses based upon clinical symptoms or mortality events, as Bd cannot be readily 
distinguished from other diseases due to its similarity in symptoms to some viral diseases and 
bacterial infections (e.g., red-leg syndrome, Densmore and Green 2007). Bd diagnosis with 
histology is more reliable than clinical diagnosis. Most authors (e.g., Hyatt et al. 2007) agree 
however, that histology is still limited in comparison to PCR because it relies upon tissues that 
are relatively intact and also upon the skill of the observer at distinguishing Bd cellular structures 
from that of the host. In contrast to the aforementioned methods, Bd diagnosis with PCR is 
“black and white”. This is especially true with end-point PCR where the observer is simply 
scoring for the presence/absence of a 300 base pair band on a gel to diagnose the disease. PCR 
and clinical diagnosis have comparable invasiveness as a procedure; both require that the 
amphibian be handled for a brief period of time for examination or swabbing in the case of PCR. 
In comparison, histology necessitates tissue collection or sacrifice of the entire animal, which 
can be problematic especially when working with rare or threatened species where the sacrifice 
of individuals may not be acceptable. Lastly, PCR differs from histology in the ease of the 
procedure. Performing histological examinations requires special training and experience; 
considerable time must be spent collecting tissue sections from various regions of the animals’ 
body to increase the likelihood of a correct diagnosis (Boyle et al. 2004). In contrast, PCR 
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techniques can readily be taught to undergraduates with a small time investment and have the 
additional benefit of allowing the researcher to include positive and negative reaction controls.  
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Management of Bd 
 Various strategies for managing Bd are currently being employed (e.g., preventing further 
spread, establishing captive assurance colonies); however, it is still too early to evaluate their 
long-term effectiveness (Woodhams et al. 2011). The Amphibian Conservation Action Plan 
(Gascon et al. 2007) emphasized that a significant proportion of their proposed budget should be 
spent on efforts related to Bd (i.e., 6% of funding should be focused on research and 
management of emerging infectious diseases with a particular emphasis on Bd, 10% on 
establishing captive breeding programs, and 1% on developing reintroduction programs, Gascon 
et al. 2007). A recent review by Woodhams et al. (2011) stressed the importance of taking an 
epidemiologically-informed approach to Bd management. Such an approach would employ site-
specific strategies on host immunity, local strain virulence, and climate, and would emphasize 
disease mitigation rather than eradication (Woodhams et al. 2011). The authors recommend 
using a three-pronged approach for Bd management consisting of: identifying mechanisms of 
disease suppression, parameterizing epizootiological models of disease and population dynamics 
for testing under semi-natural conditions, and performing adaptive management in field trials 
with natural populations (Woodhams et al. 2011). 
 Approaches such as those discussed in Woodhams et al. (2011) are a great “first step” 
towards getting Bd management ‘off the ground’; however, before many of these projects can be 
initiated, a lot more research needs to be directed towards population surveillance. As mentioned 
previously, most amphibian populations in South America, the amphibian biodiversity center of 
the world, lack population monitoring altogether. Other amphibian biodiversity host spots such 
as South East Asia are even less understood (Vié et al. 2009). Until more efforts are invested in 
population surveillance, we will continue to loose amphibian populations at an alarming rate 
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from factors such as Bd and habitat loss without even being aware that they were declining in the 
first place. The study discussed in Chapter 2 of this document, was the first to evaluate the Bd 
status of amphibians across Peru and I believe that it is a great “first step” towards protecting 
these vulnerable animals; however, it is only a “first step” in a long road to conserving 
amphibians. One of my main research goals is to illustrate the importance of continued 
investigation of Bd in these understudied, biodiverse regions. Most importantly, I hope to reveal 
the value of investing in long term population monitoring, which I believe cannot come about 
unless there are major with changes in science and policy first.  
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Goals of Dissertation  
 The goals of my research were to investigate the prevalence of Bd across Peru and to 
optimize and compare methods for detection of Bd from field samples. The remainder of this 
dissertation is divided into four chapters. In Chapter 2, I discuss the results of my sampling effort 
for Bd prevalence in Peru, which was conducted during the dry seasons of 2007 and 2008. I also 
discuss some of the implications of the results of this investigation and directions for further 
studies of Bd in Peru. In Chapter 3, I review the results from my laboratory investigation on 
techniques for field sampling of Bd. In this study, I optimized and compared methods for field 
preservation of swabs, DNA extraction, and Bd detection. In Chapter 4 I discuss the results of 
my research on methods for minimizing the effect of PCR inhibitors in the Bd assay. Lastly, in 
Chapter 5, I summarize the major results of this dissertation and discuss the intellectual merits 
and broader impacts of this research. 
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Figures 
 
Figure 1. Global diversity of amphibian species. Reprinted from the IUCN Red List (Accessed: 
May 25, 2012. 
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CHAPTER 2: BATRACHOCHYTRIUM DENDROBATIDIS IN PERU* 
Abstract 
Chytridiomycosis is an amphibian disease caused by the fungal pathogen Batrachochytrium 
dendrobatidis (Bd). This disease has been identified as one of the main causal agents of 
worldwide amphibian declines and extinctions, and as the worst infectious disease ever recorded 
among vertebrates by the Amphibian Conservation Action Plan. Prior to this investigation, very 
little was known about the prevalence of this disease across Peru, a country renowned for its high 
amphibian diversity and endemism.  Our sampling effort from the dry seasons of 2007 and 2008 
show that Bd is widely distributed throughout Peru, with among site prevalence ranging from 0 
to 25%. Bd was detected in 11 of 983 individuals sampled, and in 9 out of 38 sites ranging in 
altitude from 96-3240 meters. We detected Bd in 11 species of anurans belonging to 14 families. 
The family with the highest number of Bd-positive individuals was Hylidae with four positive 
samples, all from different species. The disease also was detected in one of two Telmatobius 
marmoratus purchased at a market in Cusco where they were being sold for human consumption 
further supporting the idea that human transport of amphibians is facilitating the dispersal of this 
Bd. We strongly recommend further studies of Bd in Peru in order to better understand the 
ecology of this devastating disease and its effects on this biodiverse region. 
 
 
 
 
 
 
 
*this manuscript with slight modifications has been published as Kosch, T.A., Morales, V., and K. Summers. 2012. 
Batrachochytrium dendrobatidis in Peru. Herpetological Review 43(2), 288–293. 
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Introduction 
 The amphibian chytrid fungus, Batrachochytrium dendrobatidis (Bd), has been well-
studied in Australia, North and Central America, and Europe, but relatively little information is 
available concerning the status of this pathogen in South America. This is especially disturbing 
given that South America contains the highest diversity of amphibian species in the world (Vié et 
al. 2009). 
 In Peru, sampling for Bd has been especially sparse, with only six studies in localized 
regions conducted to date (Table 3). The first record of Bd in Peru came from several dead 
Atelopus patazensis collected in 1999 (Venegas et al. 2008). Although recent surveys have 
shown that this species continues to persist, it is currently listed as critically endangered by the 
IUCN due to the combined effects of Bd and water pollution (IUCN 2011). Reliable data are not 
available on the status of other Atelopus species in Peru, though many appear to be declining 
(Venegas et al. 2008, von May et al. 2008), a trend seen throughout the range of this genus (La 
Marca et al. 2005). Population surveys for A. pulcher in northern Peru have not detected any 
adults in localities where they were once abundant; one of the last individuals seen was found 
dead and later tested Bd-positive (Lötters et al. 2005). Another study in northern Peru failed to 
detect Bd in 23 individuals tested using histopathological analysis (Enciso et al. 2008).  In 
southern Peru, the first record of Bd came from three of four Telmatobius marmoratus collected 
in 2002 in the Cordillera Vilcanota (Seimon et al. 2005). A later study in this region reported a 
range expansion in Bd to the highest altitude yet recorded (5348 m), which Seimon et al. (2007) 
posit may be due to the recent deglaciation and subsequent host population expansion in the 
region. Additionally, it appears Bd may be contributing to declines in one of the two host species 
investigated (Seimon et al. 2007). Most recently, Catenazzi et al. (2011) discovered dramatic 
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declines in montane amphibian species richness and abundance in southern Peru between 
surveys from 1999 and 2008-2009. They attributed these declines to chytridiomycosis rather than 
habitat loss because Bd is widespread in the region and declines occurred within the well-
protected zone of Manu National Park (Catenazzi et al. 2011). 
Recently, it has been shown that the global trade of amphibians is a major contributor to the 
worldwide dispersal of Bd (Fisher and Garner 2007, Farrer et al. 2011).  In Peru, trade of 
amphibians is fairly common, especially in large cities such as Lima and Cusco where Andean 
frogs (predominantly Telmatobius and Batrachophrynus species) are frequently sold live in 
restaurants and markets as a protein source or for their perceived medicinal properties (Angulo et 
al. 2008). Investigations have shown that many of these frogs are Bd-positive (Catenazzi et al. 
2010), indicating that they are likely contributing to spread of the disease throughout Peru as 
they are moved from capture sites to markets.  
 The aim of our investigation was to conduct a systematic survey of the current 
distribution of Bd in amphibian populations throughout Peru. Our main goal was to obtain a 
“snapshot” of the current distribution of the infection to aid in planning future research and 
management of the disease.  
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Materials and Methods 
 Field surveys of Bd prevalence were conducted during June–August of 2007 and May–
July of 2008, coinciding with the dry season. We surveyed 39 sites along the eastern slopes of 
the Andes, providing a collection of samples along both latitudinal (3.68572°S, 73.28350°W to 
13.17956°S, 71.60561°W) and altitudinal gradients (90–3240 m; Figure 2). Coordinates of each 
locality were determined using a portable GPS unit (Garmin Etrex Vista, Olathe, KS). Sites were 
surveyed using the visual encounter technique (Lips et al. 2001). For each site, two surveyors 
performed a time-constrained survey for four hours.  The primary goal of each survey was to 
capture as many individuals and species as possible. During each survey, all amphibians 
encountered were captured by hand and a new plastic bag was used each time to eliminate the 
possibility of cross contamination between individuals. For ease of species identification, only 
post-metamorphic individuals were sampled. After capture, all specimens were kept in individual 
plastic bags and stored in a cool place until each transect was completed. Appropriate measures 
were taken to prevent cross-contamination between sites (i.e., disinfection of equipment and 
footwear between sites, clean clothing, etc.).  
 During processing, a new pair of latex gloves was worn for each individual, and all 
equipment was disinfected between animals. Processing consisted of species identification, 
clinical examination for abnormalities (i.e., retained shed skin, reddening of skin), and collection 
of digital photographs of the dorsum and venter. The epidermis was swabbed using dry sterile 
rayon swabs (Medical Wire and Equipment, Durham, NC). Swabbing consisted of running a 
rayon swab 10 times over the dorsum, both sides, venter, undersides of each thigh, and five times 
on the underside of each foot, for a total of 80 swab runs per animal (Kriger et al. 2006). After 
processing, all specimens were released within two meters of their capture site (with the 
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exception of the frogs purchased at the San Pedro Market which were euthanized after 
processing). Swabs were preserved at room temperature in individually labeled vials of 95% 
ethanol.  
 DNA extractions for swabs were performed in the winter of 2008. The samples from 
2007 were extracted in 2008 due to a delay in obtaining permits. During this time, these samples 
were stored at the Museum of Natural History in Lima at room temperature. Upon arrival in the 
US, all samples were immediately placed at 5°C until DNA extraction. DNA extraction was 
performed using the PrepMan Ultra Sample Preparation Reagent (ABI), following methods 
outlined in Boyle et al. (2004).  Samples then were analyzed using a highly sensitive endpoint 
PCR Bd assay (minimum sensitivity of 0.0016 zoospores) developed in our laboratory (described 
in Chapter 3), which uses Bd-specific primers developed by Annis et al. (2004; Bd1a: 5’-
CAGTGTGCCATATGTCACG-3’, Bd2a: 5’-CATGGTTCATATCTGTCCAG-3’). The reaction 
recipe was: 1.25 μl of DNA Gold Buffer (10x, ABI), 1.0 μl of MgCl2 (16.7 μM), 2.4 μl of 
GeneAmp dNTP mix with dTTP (1000 μM, ABI), 0.5 μl of forward and reverse primers (5 μM, 
Invitrogen), 0.06 μl of AmpliTaq Gold with GeneAmp (5 units/μl, ABI), 4.29 μl of DNA grade 
water (Fisher Scientific, Pittsburg, PA), 2.0 μl of sample for a total reaction volume of 12 μl. 
Reactions were loaded into a 96-well plate and placed in the PTC-200 Thermal Cycler (ABI). 
Initially all samples were run in duplicate (i.e., two separate PCR runs/sample/plate) along with 
positive (previously amplified Bd DNA from culture) and negative controls (PCR master mix 
and H20). Inhibition controls were not used. We used the thermal cycler program: 1) 5 minutes at 
95°C, 2) 45 seconds at 93°C, 3) 45 seconds at 60°C, 4) 1 minute at 72°C, 5) repeat steps # 2-4 
for 44 more times, and 6) 10 minutes at 72°C. After thermal cycling, 8 μl of the resulting product 
was mixed with 1 µl of 6x Apex loading dye (Genesee) and loaded into a gel (8 ml of 1x TBE 
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Buffer, 1.2 g of Apex agarose, Genesee). Additionally, one well per row was loaded with 100 bp 
Promega DNA ladder (Fisher Scientific), so that the size of the PCR amplicons could be 
estimated. Gels then were immersed in 1x TBE Buffer and run at 120 volts for approximately 40 
minutes, after which gels were examined and photographed using a UV viewing apparatus. The 
number of true positives and false negatives was determined by scoring the presence/absence of 
300 bp bands on electrophoresis gels. For ambiguous samples, further PCR analyses were 
conducted. The data for each locality were summarized in terms of Bd prevalence (total number 
of infected individuals/total number of individuals sampled).  
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Results 
 Over a two-year period, a total of 983 amphibian skin swabs were collected from 39 sites 
throughout Peru. We collected samples from 36 genera of amphibians belonging to 14 families 
(Table 2, Figure 2). The results of our PCR assay showed that 11 of 983 individuals sampled 
were positive for Bd (overall prevalence = 1.0%, Table 1).  Bd was detected in amphibians at 
nine of 39 sites across a broad range of altitudes (96–3240 m, Figure 2). Among-site prevalence 
ranged from 0 to 25% (Table 1, only results from natural populations were used in this analysis, 
therefore results from San Pedro market were excluded). Bd was detected in 11 species of 
anurans from seven families (Table 2).  
The majority of Bd-positive individuals had reproductive modes associated with permanent 
bodies of water (6/11, Allobates marchesiansus, Hypsiboas melanopleura, Hyloscirtus c.f. 
phyllognatus, Hyloxalus shuar, Osteocephalus buckleyi, Telmatobius c.f. marmoratus) and/or 
had an aquatic tadpole stage (9/11, A. marchesiansus, Engystomops petersi, Hypsiboas 
melanopleura, Hyloscirtus c.f. phyllognatus, Hyloxalus shuar, Leptodactylus petersii, O. 
buckleyi, Scinax garbei, T. c.f. marmoratus ).  Five of the 11 Bd-positive individuals are known 
to utilize streams for reproduction (Allobates marchesiansus, Hyloscirtus c.f. phyllognatus, 
Hyloxalus shuar, O. buckleyi, T. c.f. marmoratus). The family with the highest number of 
infected individuals was Hylidae with four infected individuals (Table 2).  Bd was not detected in 
any of the 23 Atelopus that we sampled (three A. pulcher, 20 A. c.f. andinus). One of the Bd-
positive samples came from two Telmatobius marmoratus purchased at San Pedro Market in 
central Cusco (of unknown origin) where they were being sold for human consumption. Obvious 
clinical abnormalities consistent with possible signs of the disease chytridiomycosis were 
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detected in only three of 983 individuals (all Gastrotheca excubitor), which had retained shed 
skin on their toe pads. One of these three individuals tested positive for Bd with the PCR assay.  
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Discussion 
The results of this and previous studies indicate that Bd is widespread throughout Peru, and from 
our limited data it appears that Bd presence may not be as tightly linked with altitude as 
suggested by others (Figure 2, Bielby et al. 2008, Brem and Lips 2008, Lips et al. 2008).  This 
adds to the growing body evidence (Kriger and Hero 2008, Walker et al. 2010) that altitude may 
not have as strong an influence on disease prevalence as originally believed.  
In this study, the majority of Bd-positive individuals had reproductive modes associated with 
permanent bodies of water and/or an aquatic tadpole stage, characteristics that have been shown 
to be associated with high transmission and prevalence of chytridiomycosis (Lips et al. 2003, 
Kriger and Hero 2007).  Of these species, five are known to utilize streams for reproduction, a 
characteristic associated with susceptibility and declines in other regions (Lips et al. 2003, Kriger 
and Hero 2007, Catenazzi et al. 2011). There was a greater frequency of Bd-positive individuals 
in the family Hylidae.  Other researchers have reported a higher frequency of chytridiomycosis 
in this family (e.g., Stuart et al. 2004), which may be linked to reproductive mode (Lips et al. 
2003) and/or evolutionary history (Corey and Waite 2008). Contrary to our expectations, we did 
not detect Bd in any of the Atelopus that we sampled. Although this is the first time that a 
population of A. c.f. andinus has been sampled for Bd, this disease has been previously detected 
in other Peruvian Atelopus (A. pulcher: Lötters et al. 2005, A. patazensis: Venegas et al. 2008). 
Our data showing Bd in one of two Telmatobius marmoratus tested from the San Pedro market 
further supports the idea suggested by Catenazzi et al. (2010), that the trade of amphibians in 
Peru may contribute to the dispersal of Bd throughout the country.  
The Bd prevalence we found among sites was lower than we expected, especially in mid-
elevation regions where previous studies in other countries have reported high disease prevalence 
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(e.g., Sánchez et al. 2008). Other studies in Peru have reported among-site prevalence ranging 
from 0 to 100% (Table 3). In fact, Catenazzi et al. (2011) reported Bd prevalence as high 64–
100% (in T. marmoratus) from some of the same sites that we visited in the Department of 
Cusco. There are several possible reasons for this. First, our surveys were conducted in the dry 
season when climatic conditions may be less conducive to disease transmission and progression 
(but see Burrowes et al. 2004). Second, our within-site sample sizes may not have been large 
enough to detect the disease (95% CI=26 ± 29). Statistical modeling has shown that at least 30 
individuals need to be swabbed per locality in order to detect at least one positive individual at a 
site if the disease prevalence is 10% (Cannon and Roe 1982). As it was not always possible for 
us to collect 30 individuals per locality due to time limitations, this may explain the lower 
frequencies we observed. Lastly, although we know that the Bd assay that we used is equally 
sensitive to Bd detection techniques published by others (discussed in Chapter 3), another 
possibility for our lower number of Bd detections may be due to the presence of PCR inhibitors 
that have been known to contribute to incorrect reporting of false negatives (Garland et al. 2009).  
Another interesting observation from this investigation is that only three of 983 individuals had 
any obvious clinical abnormalities consistent with the disease chytridiomycosis, and we did not 
observe any die-offs or moribund individuals. This is may be because chytridiomycosis is 
difficult to detect by clinical examination (Green et al. 2002, Kriger et al. 2006), but may also 
indicate that the infection is not progressing to an advanced state, possibly due to host immunity 
or low virulence (especially if Bd has been present in Peru for long enough for adaptation to 
occur). Unfortunately, we are unable to distinguish between these possibilities with our limited 
data. 
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Although the results of this and previous studies demonstrate that Bd is widespread in South 
America (e.g., Brazil: Carnaval et al. 2006, Venezuela: Sánchez et al. 2008, Argentina: 
Barrionuevo and Ponssa 2008), the consequences of this disease are still relatively unknown due 
to the near complete absence of general population monitoring and Bd studies in these countries. 
In Peru, significant declines have been reported in multiple high-elevation species in southern 
Peru (Catenazzi et al. 2011), and several Atelopus and Telmatobius species are believed to 
already be extinct (Venegas et al. 2008, von May et al. 2008). Peru contains some of the highest 
amphibian diversity on record and the loss of this diversity could have severe consequences. This 
makes the lack of knowledge on Bd and population status of Peru’s amphibians especially 
alarming.  
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Tables and Figures 
Table 1. Summary of amphibian study sites in Peru sampled for Batrachochytrium dendrobatidis 
(Bd). Surveys were performed during the dry seasons (June–August) 2007 and (May–July) 2008.      
Locality Latitude Longitude Altitude (m) N Bd Positive Prevalence 
2007       
Ahuashiyacu -6.4578 -76.30843 722 15 2 0.13 
Allpahuayo Mishana -3.75067 -73.28228 102 1 0 0.00 
Bocatoma -6.4585 -76.34968 426 43 0 0.00 
Chacos Valley and  Llamaquizú -10.61583 -75.35056 1800-2100 4 1 0.25 
Chazuta -6.5692 -76.12622 235-355 42 0 0.00 
Huallaga River -6.58899 -75.91939 171-232 36 0 0.00 
Iquitos Km 23 -3.9586 -73.375 149 37 0 0.00 
Iquitos Km 71 -3.75067 -73.33228 122 15 0 0.00 
Lamas -6.38493 -76.51527 645 1 0 0.00 
Nanay River -3.68572 -73.2835 96 17 1 0.06 
Pampa Hermosa -10.9925 -75.43278 1200-1550 10 0 0.00 
Pond near Tunnel -6.43118 -76.30882 846 16 0 0.00 
Pongo de Cainarachi -6.29388 -76.23598 190-220 58 0 0.00 
San Jose -6.4194 -76.2901 470-589 58 0 0.00 
Santa Rosa -5.4406 -78.55473 1234-1270 11 1 0.09 
Sapasoa -6.89635 -76.82817 315-416 32 0 0.00 
Sauce -6.72453 -76.25318 622 5 0 0.00 
Seco River -8.59656 -76.08714 771 20 0 0.00 
Tahuayo -4.17703 -73.15365 115 26 0 0.00 
 
2008 
      
Aguaytia -9.05734 -75.66543 429 6 0 0.00 
Chacos Valley and  Llamaquizú -10.61583 -75.35056 1800-2100 2 0 0.00 
CICRA Station -12.56861 -70.09917 250-270 83 1 0.01 
Cueva de las Lechuzas -9.32867 -76.02715 656 19 1 0.05 
Huampal -10.18825 -75.57519 968 6 0 0.00 
Ivochote -12.46317 -72.96740 471-481 32 0 0.00 
Lake Milagros -9.14174 -75.99635 671-691 17 0 0.00 
Lake Yarinachocha -8.32561 -74.59022 188 29 0 0.00 
Manu Learning Center -12.78926 -71.39175 463 51 2 0.04 
Oxapampa -10.54556 -75.35835 2355 12 0 0.00 
Pilcopata -12.90997 -71.42281 480-525 49 0 0.00 
Pozuzo -10.04908 -75.54059 692 10 0 0.00 
Puente Maranura -12.96498 -72.66568 1068 22 0 0.00 
Puerto Bermudez -10.27102 -74.93673 243-309 37 0 0.00 
Puerto Inca -9.36759 -75.00175 202-229 23 0 0.00 
San Pedro Market, Cusco* -13.52384 -71.97128 3363 2 1 0.50 
Satipo -11.27665 -74.64673 719 23 0 0.00 
Shima Venzo -11.11832 -74.22433 394-474 37 0 0.00 
Tambopata Research Center -13.13333 -69.60000 350 61 0 0.00 
Wayqecha -13.17956 -71.60561 2623-3240 15 1 0.07 
*Specimen purchased from market 
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Table 2. Summary of study amphibian taxa tested for Batrachochytrium dendrobatidis (Bd) in 
Peru. N=number of individuals. 
Family N Bd 
Positive 
Prevalence Bd-positive Species 
Aromobatidae 8 1 0.13 Allobates marchesiansus 
Bufonidae 166 0 0.00  
Caeciliidae 1 0 0.00  
Centrolenidae 4 0 0.00  
Ceratophryidae 3 1 0.33 Telmatobius c.f. marmoratus* 
Dendrobatidae 242 1 0.01 Hyloxalus shuar 
Hemiphractidae 16 1 0.06 Gastrotheca excubitor 
Hylidae 212 4 0.02 Osteocephalus buckleyi, Hyloscirtus c.f. phyllognatus, 
Scinax garbei, Hypsiboas melanopleura 
Leiuperidae 12 1 0.08 Engystomops petersi 
Leptodactylidae 139 2 0.01 Leptodactylus c.f. andreae, Leptodactylus petersii 
Microhylidae 21 0 0.00  
Plethodontidae 4 0 0.00  
Ranidae 1 0 0.00  
Strabomantidae 154 0 0.00  
             *Specimen purchased from market 
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Table 3. Studies of Batrachochytrium dendrobatidis (Bd) in Peru conducted to date. 
Locality Department Study 
Year(s) 
Altitude 
(m) 
N Prevalence Citation 
Provincia de Pataz Piura 1999 2620 3 0.67 Venegas et al. 2008 
Sibinacocha 
watershed 
Cusco 2002 4450 4 0.75 Seimon et al. 2005 
Sibinacocha 
watershed 
Cusco 2003 4422-5244 24 0.21 Seimon et al. 2007 
Cainarachi valley San Martín 2003 600 1 1.00 Lötters et al. 2005 
Sibinacocha 
watershed 
Cusco 2005 5348 2 0.50 Seimon et al. 2007 
Abra Huallahualla Cusco 2008 3100–4550  65 0.26 Catenazzi et al. 
2011 
Abra Malaga Cusco 2008 3300–4050 8 0.13 Catenazzi et al. 
2011 
Kosnipata Valley Cusco 2007, 2008 1250-3700 1097 0.12 Catenazzi et al. 
2011 
Privada Huiquilla Amazonas 2007, 2008 2800 23 0.00 Encisco et al. 2008 
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Figure 2. Study sites in Peru sampled for Batrachochytrium dendrobatidis (Bd). Circles = 
sample sites with circle diameter proportional to number of samples; stars= sites where Bd was 
detected, and triangles= Bd-positive sites reported by others (see Table 3). 
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Figure 3. Three species that tested positive for Batrachochytrium dendrobatidis (Bd) in this 
study: A) Hyloscirtus c.f. phyllognatus, B) Telmatobius c.f. marmoratus, and C) Gastrotheca 
excubitor. 
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CHAPTER 3: COMPARISON OF TECHNIQUES FOR FIELD SAMPLING OF 
BATRACHOCHYTRIUM DENDROBATIDIS USING RAYON SWABS 
Abstract   
The majority of methods papers for Batrachochytrium dendrobatidis (Bd) to date have focused 
on techniques for sampling Bd in developed countries. In order to facilitate the increased 
sampling for Bd in other areas (particularly biodiversity hotspots), it is imperative to improve the 
feasibility and reliability of testing for Bd in developing countries. In this study we compare the 
use of 95% ethanol, DMSO-NaCl solution, and dry swabs for sample preservation, DNeasy vs. 
PrepMan Ultra for DNA extraction, and end-point PCR vs. quantitative (qPCR) for Bd detection. 
Our results show that the most advantageous techniques for a Bd-field study are swab 
preservation in 95% ethanol, DNA extraction with DNeasy, and the end-point PCR disease 
assay. Here we outline the protocols, show the results of our methods comparisons, and discuss 
the pros and cons of each method.  
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Introduction 
 The amphibian chytrid fungus Batrachochytrium dendrobatidis (Bd) has been implicated 
as the worst infectious disease ever detected in vertebrates (Gascon et al. 2007). This pandemic 
has already been implicated in the extinction of 159 species of amphibians (Vié et al. 2009) and 
as it continues to spread is likely to be the cause of many more extinctions.  
 The majority of methods papers to date have focused on techniques for sampling Bd in 
developed countries, where most investigations have taken place. In order to facilitate increased 
sampling for Bd in developing regions (particularly biodiversity hotspots, i.e., the Amazon basin, 
Central Africa, South East Asia), it is imperative to improve the feasibility and reliability of 
testing for Bd in these areas. Many of the major constraints of working in developing countries 
involve refrigeration of samples, exportation, and obtaining supplies. Here we address these 
issues in our comparison of methods for sample preservation, DNA extraction, and Bd detection.  
 The preservation of amphibian skin swabs for Bd detection has been discussed by others 
(e.g., Hyatt et al. 2007, Van Sluys et al. 2008), but has not been tested for long durations (i.e., 
beyond 14 or 7 days respectively) under field temperatures. Here we test three DNA preservation 
techniques: dry preservation, 95% ethanol, and DMSO-NaCl solution (hereafter referred to as 
DMSO solution) for Bd samples collected with rayon swabs. 
 The majority of Bd investigations to date have used PrepMan Ultra (ABI), following the 
methods first outlined in Boyle et al. (2004) for DNA extraction. Using this method has several 
drawbacks. First, a tissue homogenizer is required for lysing cells.  A tissue homogenizer is not a 
standard piece of equipment in most laboratories and can add substantial cost to a project. 
Additionally, the procedure calls for the use of zirconium/silica beads to aid in homogenization 
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and special tubes that can withstand the stress of homogenization; this further increases 
preparation time and costs.  Lastly, although this method works fairly well with pure cell 
cultures, problems may occur when using PrepMan Ultra to extract DNA from field samples 
because this technique does not have washing steps to remove PCR inhibitors such as soil and 
leaf litter contaminants.  
 Hyatt et al. (2007) noted that PCR inhibitors are one of the leading causes of failure to 
detect Bd-positive individuals. For this reason, they developed a method for testing for the 
presence of inhibitors. This adds an extra step to the PCR assay, and considerably increases the 
cost (Internal positive control agent is $230 for 200 reactions, ABI). The DNeasy kit (Qiagen) 
has multiple advantages in comparison with the PrepMan Ultra technique. All the supplies for 
performing the DNeasy procedure come complete in a user-friendly kit; no additional laboratory 
equipment beyond the standard microfuge, water bath and vortex are required. This technique 
also utilizes multiple washing steps and a DNA column, thus, the end product is colorless and 
much less likely to contain PCR inhibitors (Qiagen, July 2006). Here we compare the 
effectiveness, convenience, and costs of PrepMan Ultra and DNeasy. 
 The recommended procedure for Bd detection is currently quantitative (qPCR) using the 
Taqman probe (Kriger et al. 2006, Hyatt et al. 2007, but see Garland et al. 2011). However, due 
to some drawbacks of this method (e.g., high start-up costs, frequent background amplification), 
we attempted to develop an end-point PCR method with sensitivity and reliability comparable to 
the widely used qPCR. Because there are already several papers published that discuss the 
analytical sensitivity of qPCR (e.g., Boyle et al. 2004, Kriger et al. 2006), we will not evaluate 
this method here. Instead, we will compare the results of our end-point PCR to those already 
published for qPCR.  Multiple papers have been published outlining various components and 
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techniques of the Bd assay (e.g., Hyatt et al. 2007). Due to the important conservation 
implications of detecting this organism in a population, it is crucial that researchers use 
standardized, consistent methods. Consistency is critical to minimize the occurrence of false 
negatives during sampling efforts. Here we compare various widely-used methods for 1) DNA 
extraction from swabs, 2) swab preservation, and 3) detection of the disease organism. For each 
technique we will compare procedure times, cost, sensitivity, likelihood of error, and qualitative 
and quantitative output. Our hope is that providing an easy, cost effective method will promote 
research by smaller laboratories and provide a means for researchers unfamiliar with molecular 
techniques to perform in-house Bd assays.  
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Materials and Methods 
Bd culturing, cell counts. The Bd strain used in these comparisons was originally obtained from 
Joyce Longcore (Jel 423) in December of 2009. Cultures were maintained on Petri plates at 25°C 
using tryptone agar (5 g tryptone, 12 g agar, 500 ml distilled water) and using aseptic techniques 
(Longcore et al. 1999). To collect zoospores, plates were flooded with sterile distilled water and 
incubated at room temperature for 20 minutes. Excess liquid was collected from plates, and 
resulting zoospore solution was mixed 1:1 with Trypan Blue (Invitrogen) to improve the ease of 
counting cells. Cell density then was estimated using a hemocytometer and a serial dilution was 
performed to dilute cell concentrations to 100, 10 and 1 zoospores/ml as described in Boyle et al. 
(2004). Differing cell concentrations were utilized for each of our method comparisons so that 
the sensitivity of each method at detecting low level DNA concentrations could be examined (as 
would be expected from field samples collected during earlier stages on infection).  
Swab preservation. We compared three methods of swab preservation (dry, DMSO, and 95% 
ethanol) using two different Bd sources (from culture and infected frogs) for their ability to 
preserve DNA. Before swab collection, microvials were prepared by adding either 1000 μL of 
DMSO solution (DMSO solution prepared using the protocol described in Dawson et al. 1998) 
or 95% ethanol. Microvials for the dry swabs treatment did not require preparation. Bd swabs 
from culture then were prepared by immersing sterile swabs (MW113, Medical Wire and 
Equipment) into tubes with the various cell concentration standards set up previously. Each swab 
was immersed in the solution for five seconds and cell absorption was maximized by gently 
twisting the swab between the thumb and forefinger. Four swabs were collected from each of 
three different live, wild-caught frogs known to be infected with Bd (Hyla versicolor complex). 
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Each frog was swabbed systematically (i.e., 10 times on the dorsum, 10 times on the venter, five 
times on each side, and five times on each foot, Kriger et al. 2006b).   
 For our Bd in culture swab preservation comparison, a 3x3x2 full factorial design was 
used to ensure all possible combinations of treatments among experimental groups. Groups 
consisted of: 95% ethanol, dry or DMSO solution→ 5 or 30°C → 1, 10, or 100 zoospores/ml. 
Five replicates were constructed for each experimental unit resulting in a total of 90 replicates 
along with six negative controls (swabs inoculated with sterile water to ensure that cross 
contamination did not occur between replicates). All swab replicates were prepared at the same 
time using the same stock zoospore concentrates. Swabs were incubated at the desired 
temperature for 90 days.  
 Swabs from individual live frogs were divided into treatment groups of: 1) 95% ethanol, 
6 days; 2) 95% ethanol, 68 days; 3) Dry, 6 days; and 4) Dry, 68 days. Ethanol treatment swabs 
were preserved in 95% ethanol immediately after swabbing until DNA extraction (after six or 68 
days). Dry treatment swabs were placed in microvials immediately after swabbing with no 
preservative until DNA extraction (after 6 or 68 days). All swabs were preserved in an incubator 
at 30°C until DNA extraction.  
 At the end of the incubation period, DNA was immediately extracted from swabs using 
the DNeasy methods outlined below. Replicates then were amplified using independent end-
point PCRs (see PCR section for methods), and the resulting products were compared by 
examining electrophoresis gels for the presence/absence of a 300 bp band.  
 Before DNA extraction, swabs preserved with 95% ethanol or DMSO were spun down 
for three minutes at 13,000 rpm in a microfuge to pellet excess material. The majority of the 
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supernatant fluid then was gently removed with a pipette. After this, the ethanol tubes were 
placed in an incubator overnight (with caps off) to evaporate off the remaining ethanol. DMSO 
tubes were first incubated overnight with 1000 μl of DNA free water to remove excess salts, and 
after removal of excess water with a pipette, they were incubated a second night (with caps off) 
for desiccation. Dry samples did not require preparation for DNA extraction. To increase sample 
yield, all DNA extractions were performed in the original microvial (from the sample 
preservation procedure) with the desiccated swab.  
DNA extraction techniques. A DNA extraction comparison was performed using Bd swabs 
prepared from serially diluted zoospores as outlined above. Treatment groups consisted of: 
DNeasy or PrepMan Ultra→ 1, 10 or 100 zoospores. Five replicates were constructed for each 
experimental unit resulting in a total of 30 replicates. Prior to DNA extraction, swabs were 
incubated dry at 5°C for 24 hours.   
 The PrepMan Ultra procedure we tested is discussed in detail in Hyatt et al. (2007). 
Briefly, swabs were placed in microvials containing 30-40 mg of zirconium/silica beads (0.5 mm 
diameter, BioSpec Products) after which 50 μl of PrepMan Ultra was added to each tube. Tubes 
then were placed in the tissue homogenizer (Mini Beadbeater, BioSpec Products) for 45 seconds 
followed by centrifugation (30 seconds at 13,000 rpm). These homogenization and centrifugation 
steps were repeated once. Lastly, tubes were placed in a hot block at (10 minutes at 100°C) and 
resulting supernatant fluid (approximately 20 µl) was transferred into new vials and immediately 
frozen. Because undiluted preparations of PrepMan Ultra have been shown to be inhibitory 
(Boyle et al. 2004), we diluted samples 10
-1
 before setting up PCR.  
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 We used a modified version of the DNeasy procedure for extraction of DNA from animal 
tissues (Qiagen, July 2006). Swabs were placed in individual tubes with 180 μl of 1:1 Buffer 
ATL and 20 μl of Proteinase K, vortexed and then incubated at (3 hours at 56°C). After 
incubation, 400 μl of Buffer AL: 95% ethanol was added to each tube, vials were then vortexed, 
and the resulting supernatant fluid was added to DNA spin columns (Qiagen). Spin columns 
were centrifuged (1 minute at 8,000 rpm) and resulting flow through discarded. Next, 500 μl of 
Buffer AW1 was added followed by centrifugation (1 minute at 8,000 rpm), the resulting flow 
through was discarded. After this, 500 μl of Buffer AW2 was added and centrifugation was 
performed (3 minutes at 13,000 rpm). Spin columns then were moved to new microcentrifuge 
tubes and incubated with 200 μl of Buffer AE for 1 minute at room temperature followed by 
centrifugation (1 minute at 8,000 rpm). This process was repeated once, and then tubes were 
immediately frozen. Replicates from all treatments were amplified using end-point PCR (see 
PCR section for methods) and the concentration of the resulting products was compared using 
gel electrophoresis.  
Bd assay. An end-point PCR assay was optimized for detection of low levels of Bd DNA using 
the primer pair (Bd1a: 5’-CAGTGTGCCATATGTCACG-3’, Bd2a: 5’-
CATGGTTCATATCTGTCCAG-3’) developed by Annis et al. (2004). Reaction recipe was as 
follows: 1.25 μl of DNA Gold Buffer (10x, ABI), 1.0 μl of MgCl2 (16.7 μM), 2.4 μl of 
GeneAmp dNTP mix with dTTP (1000 μM, ABI), 0.5 μl of forward and reverse primers (5 μM, 
Invitrogen), 0.06 μl of AmpliTaq Gold with GeneAmp (5 units/μl, ABI), 4.29 μl of DNA grade 
water, 2.0 μl of sample DNA extract for a total reaction volume of 12 μl. Reactions were loaded 
into a 96-well plate to increase efficiency and covered with aluminum film (ABI) and placed in a 
PTC-200 thermal cycler (Gene Tools). 
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  We developed the following thermal cycler program for use with our PCR master mix: 1) 
5 minutes at 95°C, 2) 45 seconds at 93°C, 3) 45 seconds at 60°C, 4) 1 minute at 72°C, 5) repeat 
steps # 2-4 for 44 more times, and 6) 10 minutes at 72°C. The resulting product (8 μl) was mixed 
with 1 μl of loading dye (6X; Apex) loaded into a gel (8 ml of 1x TBE Buffer, 1.2 g of agarose; 
Apex). Additionally, one well per row was loaded with 100 bp DNA ladder (Promega), so that 
the size of the PCR amplicons could be estimated. Gels were immersed in 1x TBE Buffer and 
120 volts of current then were passed through for approximately 40 minutes, after which gels 
were examined and photographed using a UV-viewing apparatus. Wells containing a 300 bp 
band were deemed positive. The analytical sensitivity (i.e., lowest detectable concentration) of 
this method was compared to that of published results for qPCR (0.1 zoospores, Boyle et al. 
2004) using a Bd molecular standard obtained from Pisces Molecular LLC (Boulder, CO).  
Sequencing. In addition to testing the effectiveness of PrepMan Ultra and DNeasy at yielding 
sufficient quantities of DNA for a PCR-based disease assay, we also were interested in whether 
or not extraction technique influences the “quality” of the DNA for sequencing. This was 
investigated using a subset of confirmed positive samples of differing zoospore concentrations 
from the extraction comparison and five primers that have been previously shown to amplify  
Single Nucleotide Polymorphism (SNP) containing loci (Morehouse et al. 2007, Fisher et al. 
2009): C5(BdC5F:5’TAATAGCGCCGACCGAACTA-3’, BdC5R: 5’-
ATGCCAAACCATGAGCAAAT-3’), C18(BdC18F: 5’-GCGAATACGACTGCAAATGA-3’, 
BdC18R: 5’-TGAGCTCTAGCCGACATTGA-3’), C24(BdC24F: 5’-
GACAATGTGCTCACGGCTTA-3’, BdC24R: 5’-CTCTCCAAGGCTGAATCTGG-3’), 839 
(8392X2F: 5’-CATCGGGTTTGTCATTGCCTGC-3’, 8392X2R: 5’-
TATGGCATGTGGTCTACTCTGTCC-3’), and 870 (8702X2F: 5’-
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GGATCTGCCAGTTTCGATCTACTCG-3’, 8702X2R: 5’-
GAATATGGCATGGGAGAAGTAGCC-3’). PCR’s for the SNP primers were set up using the 
same parameters as outlined above in the Bd end-point PCR. PCR products were purified for 
sequencing by performing an ExoSAP-IT clean-up reaction (USB), and sequenced using a 3130 
Genetic Analyzer (ABI) and BigDyeTerminator v3.1 Cycle Sequencing Kit (ABI). Resulting 
sequences were aligned for product verification using Sequencher (v. 4.1.4) and Mesquite (v. 
2.74) and alignments were examined qualitatively for accuracy.   
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Analysis 
Scoring electrophoresis gels. In order to compare the effectiveness of each of the procedures 
tested, electrophoresis gels were scored for the presence/absence of bands of the appropriate 
length for the primer pair used in the reaction (e.g., the 300 bp band when using the Bd1A/Bd2A 
primers). Replicates were termed “experimental positive” if the appropriate band was detected 
on the electrophoresis gel and “true positive” if the replicate was known to contain Bd DNA 
template at the beginning of the experiment. Presence/absence data from each experiment was 
then used to construct a Chi-square 2x2 contingency table from which p-values were calculated 
in order to test the null hypothesis that results were independent of treatment.  
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Results 
Swab preservation comparison. There was no difference in the likelihood of detecting Bd among 
swab preservation techniques when using swabs from Bd grown in culture (Table 4, Figure 4). 
When performing the same comparison using swabs from live frogs, however, the 95% ethanol 
technique worked marginally better (6 days: x
2
=6, df=1, p=0.0143, 68 days: x
2
=2.4, df=1, 
p=0.1213, Table 5). Preparation and processing time was greatest in the DMSO and 95% ethanol 
preservation techniques and lowest in the dry preservation method (Table 6).  
DNA extraction techniques. The detection rate of Bd was significantly greater in three out of six 
of the primer pairs tested when using DNeasy as the extraction agent (870: x
2
=5.3333, df=1, 
p=0.0209, C24: x
2
=5.3333, df=1, p=0.0209, C5: x
2
=8.5714, df=1, p=0.0034, Table 7, Figure 5). 
DNA sequences of PCR products did not differ qualitatively among treatments: the height, 
clarity and distinguishability of peaks in the electropherograms derived from the respective 
treatments were similar (results not shown). Efficiency also was greater in the DNeasy treatment 
as estimated by the band intensity, Figure 5). Costs for each procedure were fairly similar, 
especially if the additional costs of purchasing a homogenizer and internal positive controls are 
factored in for the PrepMan Ultra procedure (DNeasy: $2.33/rnx vs. PrepMan Ultra: $1.70/rnx, 
Table 8). With regard to procedure duration, the DNeasy procedure takes longer (17 vs. 11 
minutes), especially if the incubation period is factored in (197 vs. 21 minutes, Table 8).  
Bd assay. Our end-point PCR was capable of reliably detecting Bd DNA molecule quantities as 
low as 0.275 molecules (or approximately 0.0016 zoospores, Table 9, Figure 6).The cost of 
performing the Bd-PCR assay, excluding equipment, was approximately $0.42 per sample; in 
contrast, the cost per sample for the Taqman qPCR assay was approximately $1.51 (Table 9). An 
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analysis of time per procedure showed that the Taqman qPCR assay takes considerably less time 
than the end-point PCR assay (88 vs. 265 minutes respectively, Table 9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
61 
 
Discussion 
Swab preservation comparison. Although the swab preservation techniques we tested worked 
similarly well across treatments (Table 4, Figure 4), there are some caveats to consider when 
choosing a field preservation method. First, the DMSO and ethanol methods have longer 
preparation and processing times (Table 6), which may be problematic when working with a 
large volume of samples. Second, some airlines and shipping companies have restrictions for 
shipping or exporting flammable or hazardous chemicals. Third, liquids can add a considerable 
amount of weight to baggage, especially if the preservatives cannot be purchased in study area 
and must be transported in bulk. Lastly, although the dry preservation method may seem the 
most attractive due to decreased preparation and processing time and ease of shipping, potential 
problems may arise with this method when storing swabs from live frogs for long periods of time 
at optimal temperatures for microbial growth as these organisms may interfere with detection of 
Bd. Overall, none of the preservation methods that we tested stood out above the rest as being the 
best for general use, so we recommend choosing the technique that works best based upon one’s 
study system. 
DNA extraction. The DNeasy method outperformed PrepMan Ultra in efficiency (Figure 5). This 
contrasts with the results of Boyle et al. (2004) which reported that PrepMan Ultra was 
marginally more efficient than DNeasy. DNeasy also outperformed PrepMan Ultra in 
sequencibility of extracts (results not shown) and in consistency (as determined by the number of 
true positives; Figure 5, Table 7). This was especially obvious in the replicates with lower initial 
zoospore quantity (i.e., 1 and 10 zoospores/ml). Because many field-collected samples may have 
low quantities of Bd (e.g., earlier infection stages, resistant individuals), using PrepMan Ultra as 
a DNA extraction agent can potentially lead to failure to detect the presence of the disease in Bd-
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positive individuals. PrepMan Ultra has two other drawbacks. This method produces a lesser 
product volume (i.e., 20 μl vs. 400 μl with DNeasy), which can be problematic if one plans to 
perform multiple reactions. PrepMan Ultra also may be less capable of removing PCR inhibitors 
(as indicated by yellowish coloration after extraction of field samples, data not shown). PCR 
inhibitors are often present in field samples and will therefore increase the risk of obtaining false 
negatives. The drawbacks to the DNeasy method are the higher product costs and greater 
processing time (Table 8); however, these minor issues are more than made up for by the lower 
likelihood of getting false negative results.  
End-point PCR assay. Using the Taqman qPCR assay, Kirshstein et al. (2007) found that Bd 
zoospores contain 169 copies of the Bd ribosomal RNA gene ITS-1 region. This falls within the 
range of 60 to 220 found for other fungi (Simon et al. 2005). Using the copy number estimate of 
Kirshstein et al. (2007) of 169 DNA copies per zoospore we estimate that our endpoint PCR 
assay (Figure 6) is similar in sensitivity if not more sensitive than the qPCR Taqman assay 
(0.275 DNA molecules or 0.0016 zoospores vs. 16.9 DNA molecules or 0.1 zoospores reported 
by Boyle et al. 2004 and Kriger et al. 2006). Unfortunately, it is not possible to make a direct 
comparison of assay sensitivity because our Bd standard was prepared and quantified differently 
than that used by Boyle et al. (2004).  Since, the Boyle Bd standard is no longer being 
distributed, the standard used in this sensitivity test was a plasmid molecular standard purchased 
from Pisces Molecular. This standard is prepared by inserting the Bd ribosomal RNA gene ITS-1 
region into a plasmid and then quantifying plasmids (previously replicated in E. coli) using a 
spectrophotometer. Because preparations of standards using this method are less variable than 
standard preparations that count cells with a hemocytometer (e.g., the Boyle standard, Ludwig 
and Schleifer 2000, Haque et al. 2003), we are reasonably confident of our results  (assuming 
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that the number of DNA template molecules per zoospore reported by Kirshstein et al. (2007) is 
accurate).  
 Other major factors to consider when choosing between end-point PCR and qPCR are 
specificity, costs, procedure duration, and project goals.  One of the major benefits of end-point 
PCR is that it has greater specificity (ability to correctly distinguish between positive and 
negative samples) than qPCR due to differences in interpretation of results. End-point PCR 
results are examined by performing gel electrophoresis and looking at the resulting bands. When 
performing the Bd assay using the primers developed by Annis et al. (2004), the electrophoresis 
procedure produces a 300 bp band in Bd-positive individuals which can easily be distinguished 
from primer dimers (bands <50 bp).  In contrast, qPCR results are analyzed using a computer 
readout, which displays information conveying strength of fluorescence or product accumulation 
vs. cycle number. The main problem with using qPCR for presence/absence studies is that 
positive results can sometimes be ambiguous. This is because qPCR does not distinguish DNA 
fragments by size, but rather by fluorescence. Since there is always some degree of nonspecific 
binding of the fluorescent dyes, the prevalence of background noise  can make it difficult to 
definitively distinguish between Bd-positive or negative individuals (especially if the infection 
load is small). Another benefit of end-point PCR is that initial equipment and reagent costs are 
considerably lower than the Taqman qPCR assay (Table 9).   
 Although qPCR does have some drawbacks, one of the major benefits to this technique is 
that it allows the researcher to estimate the quantity of DNA in the original sample. This estimate 
is performed by comparing the reaction Ct value against a standard curve made from samples of 
known concentrations. Estimation of DNA quantity often is used to approximate disease severity 
in chytridiomycosis studies (e.g., Kriger et al. 2007, Briggs et al. 2010). However, as attractive 
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as this method may seem for estimating host infection load, it has been criticized by others for 
methodological errors (e.g., reproducibility among samples and between labs, Wong and 
Medrano 2005). When performing amplification at a logarithmic scale, such problems can lead 
to considerable variation among samples and minor differences such as host size, swabbing 
method, pipetting techniques, and reagent age or batch number can have a dramatic effect on 
quantification (Freeman et al. 1999, Wong and Medrano 2005). Another benefit of using qPCR 
is that the procedure is considerably less time-consuming; fewer cycles are required for target 
detection and gel electrophoresis is unnecessary. The faster throughput time of qPCR may make 
it an advantageous technique for some studies, especially when time is extremely limited or for 
large-scale sampling efforts.  
Overall, although qPCR has some advantages relative to end-point PCR (e.g., quantification and 
speed), we believe that end-point PCR is the better method for Bd disease assays. End-point PCR 
clearly distinguishes between positive and negative samples, there is a lower risk of minor 
variations in protocol leading to large differences in results, and it is considerably less expensive.  
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Tables and Figures 
Table 4. Ratio of experimental positives to true positives of rayon swabs from Bd culture 
detected using the end-point PCR assay for each preservation method. Zs=zoospores. 
 Temperature Zoospore concentration 
Preservative 5°C 30°C 100 zs/ml 10 zs/ml 1 zs/ml 
95% Ethanol 15/15 14/14 5/5 5/5 4/4 
Dry 15/15 15/15 5/5 5/5 5/5 
DMSO 14/15 13/15 4/5 5/5 5/5 
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Table 5. Ratio of experimental positives to true positives of rayon swabs from Bd infected frogs 
detected using the end-point PCR assay for each preservation method.  
Preservative Preservation time 
  6 days 68 days 
95% ethanol 6/6 6/6 
Dry 2/6 4/6 
P-Value 0.0143 0.1213 
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Table 6. Comparison of DNA preservation techniques. 
Preservative Cost/sample Extra 
Preparation 
Required 
Extra 
Processing 
Time 
Potential Issues w/ Field 
Work 
95% ethanol 
 
$0.05 yes 24 hours More weight, shipping 
restrictions due to 
flammability 
Dry 
 
$0.00 no none Microbial growth 
interference w/DNA yield 
DMSO 
 
$0.10 yes 48 hours More weight, shipping 
restrictions due liquid 
hazard level 
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Table 7. Ratio of experimental positives to true positives detected using the end-point PCR assay 
for each the two extraction methods and six different primers tested. 
Extraction 
Method 
Primers 
 Bd  870 C24 C5 C18 839 
DNeasy 14/15 5/6 5/6 6/6 4/6 4/6 
PrepMan 
Ultra 
12/15 1/6 1/6 1/6 2/6 2/6 
P-Value 0.6215 0.0209 0.0209 0.0034 0.2482 0.2482 
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Table 8. Comparison of DNA extraction techniques. 
Extraction 
Method 
Cost/sample Time/sample Yield Sequencible 
Products 
Extra 
Equipment 
DNeasy $2.33 17 min* 400 μl yes no 
PrepMan 
Ultra 
$1.70 11 min** 20 μl some yes 
*Plus 3 hours for incubation, **Plus 10 minutes incubation 
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Table 9. Comparison of Batrachochytrium dendrobatidis (Bd) PCR assays. Zs=zoospores. 
Extraction 
Method 
Cost/sample Thermal 
Cycler 
Cost 
Time/sample Sensitivity False 
Positives 
Sample 
Quantification 
End Point $0.42 $3,800 265 min* 0.1 zs no no 
qPCR $1.51 $38,500 88 min* 0.275 
molecules 
yes yes 
*Includes time in thermal cycler 
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Figure 4. Electrophoresis gel images from DNA preservation methods comparison. Swabs were 
stored at 30°C for 90 days before extraction. 
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Figure 5. Representative gels for DNA extraction methods comparison. Zp=zoospore count/ml. 
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Figure 6. Electrophoresis gel image from end-point PCR sensitivity assay.  
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CHAPTER 4: TECHNIQUES FOR MINIMIZING THE EFFECT OF PCR INHIBITORS IN 
THE CHYTRIDIOMYCOSIS ASSAY 
Abstract 
Since the discovery of Batrachochytrium dendrobatidis (Bd) in 1998, several methods have been 
utilized for detection; among these PCR from skin swabs is accepted as the best method due to 
its high sensitivity, non-invasiveness and ease of use. However, PCR is a chemical reaction that 
is dependent upon the presence of non-degraded DNA template and reaction components that do 
not inhibit the process. These ingredients are crucial in order for the amplification reaction to 
proceed and accurate detection of the pathogen to occur. Here, we report on a comparison of four 
techniques that can be utilized for DNA extraction and of four techniques for analyzing Bd 
samples post-DNA extraction which minimize the inhibitory effects of humic acid on PCR. In 
order to dramatically improve the reliability of the Bd PCR assay, we recommend the use of the 
DNeasy kit (Qiagen) for DNA extraction and an end-point PCR assay with Amplitaq Gold Taq 
polymerase (ABI) and bovine serum albumin (BSA) due their effectiveness at removing humic 
acids, low cost, and relative ease of use.  
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Introduction 
Chytridiomycosis is an emerging infectious disease of amphibians caused by the fungal pathogen 
Batrachochytrium dendrobatidis (hereafter Bd). This disease has contributed to major declines 
and extinctions of amphibians worldwide (Fisher et al. 2009). Since its discovery and subsequent 
description, detection techniques for chytridiomycosis have improved considerably in reliability 
and sensitivity. However, as we will demonstrate, there are still many issues with the Bd assay 
that need to be resolved before it will be up to par with the quality of standard assays for most 
diseases.  
Despite the high sensitivity and relative ease of use of the PCR method for Bd detection, the 
reliability of this procedure is often plagued by a high probability of false negatives (e.g., up to 
72.5% of reactions in one study, Garland et al. 2010). This can have devastating consequences, 
especially given that disease management decisions may be influenced by this type of data. One 
of the main contributors to PCR failure is reaction inhibition. Such inhibition is especially 
problematic in field studies where contamination by exogenous substances (e.g., soil and dust) is 
common, and where samples frequently vary in chemical characteristics (Wilson 1997). Humic 
acids are cited as the main contributor to PCR inhibition in environmental samples (Wilson 
1997), although other compounds such as fulvic acids, metals and polysaccharides can also have 
inhibitory effects (Tsai and Olson 1992). Humic acids are poly-phenolic compounds produced 
during the degradation of organic materials. These compounds are known to interfere with the 
binding of Taq polymerase (Wilson 1997), and have been shown to completely inhibit PCR 
when present in quantities of as low as 1ng per 50µl reaction (Kermekchiev et al. 2009). 
Unfortunately, due to their physico-chemical similarities to DNA (i.e., high molecular weight 
and negative charge), these compounds react in the same way as DNA molecules with the 
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reagents used in most extraction procedures (e.g., DNeasy, Qiagen), ultimately leading to their 
co-purification along with the target DNA (Tsai and Olson 1992).  
Such problems are well understood in soil and fecal studies (e.g., Wilson 1997), but are 
commonly overlooked in other types disease surveys. In the literature on chytridiomycosis 
detection, PCR inhibition is rarely mentioned (but see Garland et al. 2010). In fact, the most cited 
method paper on the Bd assay (Boyle et al. 2004, 224 citations) does not even mention PCR 
inhibition. In addition, even though a more recent paper by the same authors does mention 
problems with inhibition (in 25% of their samples in one experiment, Hyatt et al. 2007), the only 
solution that they offer for this problem is dilution of “problematic” samples, a procedure that 
they did not test for effectiveness. Although dilution of inhibitory samples has been shown to be 
effective in some cases (Tsai and Olson 1992), the effectiveness of this method is sample 
specific, making it too unreliable for field samples (e.g., due to their high variance in inhibitor 
concentration, chemical make-up, and target DNA concentration, Kermekchiev et al. 2009).   
Here, we test the effectiveness of several techniques developed by researchers working with soil 
and fecal samples for dealing with humic acid inhibition. Our study is divided into two major 
sections, depending upon whether the technique deals with samples pre or post-DNA extraction. 
For the DNA extraction component, we tested the efficacy of four DNA extraction kits at 
removing inhibitors: DNeasy (Qiagen), QIAamp DNA Stool (Qiagen), PowerLyzer PowerSoil 
(MoBio), and PrepMan Ultra (ABI). For post-DNA extraction methods, we tested the 
applicability of four techniques: Amplitaq Gold (ABI), Bovine Serum Albumin (BSA, Sigma 
Aldrich), PowerClean DNA Clean-up Kit (MoBio), and inhibitor resistant Taq Polymerase 
mutants (DNA Polymerase Technologies).  
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Materials and Methods 
Preliminary Testing 
 The occurrence of PCR inhibition was estimated by examining PCR results for the 
presence/ absence of primer dimers (<50 bp bands) using 94 amphibian skin swabs from 
Peruvian amphibians collected in 2010. Swabs were extracted with DNeasy following the 
protocol detailed below. To further verify the occurrence of PCR inhibition, a subset of three 
samples was serially diluted and spiked with Bd from culture (for visualization) and then 
examined for the presence/absence of a 300 bp band.  
Experimental Sample Preparation 
 Experimental samples were prepared by adding 20 µl of a previously frozen liquid 
culture of Bd (gel 197 obtained from Joyce Longcore) or distilled water (for negative controls) 
along with sterile rayon swabs (MW113, Medical Wire and Equipment) to 1.7 µl microfuge 
tubes. For consistency, all treatments were set-up from the same Bd culture stock tube. A dilution 
series of humic acid (Sigma-Aldrich) was prepared for comparisons of the methods at initial 
concentrations of 10, 1, 0.1, 0.01, and 0.001 µg/µl. Humic acid solution was then added to 
samples before performing each technique so that the final reaction concentration was consistent 
across all tests (0.8 to .00008 µg/µl). For simplicity, initial concentrations of humic acid will be 
used hereafter when referring to results. The HA concentrations for the PowerClean comparison 
differ from those of the other methods because the sample starting volume had to be increased to 
150 µl with water for the method to be effective. Due to this disparity, pre-PowerClean results 
(using Amplitaq Gold) are shown with post-PowerClean results for comparison. 
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DNA Extraction Solutions 
DNeasy. The DNeasy procedure was performed according to the Bench Protocol for Animal 
Tissues outlined in the Qiagen handbook (July 2006). Several steps were slightly modified: Step 
2: incubation was performed for 3 hours; Step 3: Buffer AL and 95% ethanol were premixed; 
and Step 7: was repeated twice. Care was taken to avoid contact of the DNA column with the 
flow-through, (this was especially true after Step 6, as ethanol carryover can interfere with 
subsequent reactions, Qiagen, July 2006).  
QIAamp DNA Stool. This procedure was performed following the protocol outlined in the 
Qiagen handbook for the Isolation of DNA from Stool for Pathogen Detection (April 2010). 
Initially, two lysis temperatures (70 and 95°C) for Step 3 were tested for efficacy (results not 
shown) as both temperatures performed similarly lysis at 70°C was utilized thereafter.  
PowerLyzer PowerSoil. The PowerLyzer PowerSoil procedure was performed according to the 
Experienced User Protocol in the MoBio Instruction Manual (v. 05212010). The only deviations 
from the manual were during the homogenization step of this procedure, in which a different 
apparatus was used (Mini Beadbeater, BioSpec Products), and the homogenization time was 
extended to 50 seconds (rather than 45) to fit the minimum time settings on the device.  
PrepMan Ultra. The PrepMan Ultra procedure we tested is discussed in detail in Hyatt et al 
(2007). Briefly, swabs were placed in microvials containing 30-40 mg of zirconium/silica beads 
(0.5 mm diameter, BioSpec Products) after which 50 μl of PrepMan Ultra was added to each 
tube. Tubes were then placed in the tissue homogenizer (Mini Beadbeater, BioSpec Products) for 
50 seconds followed by centrifugation (30 seconds at 13,000 rpm). Homogenization and 
centrifugation steps were then repeated once. Lastly, tubes were placed in a hot block at (10 
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minutes at 100°C) and resulting supernatant fluid (approximately 20 µL) was transferred into 
new vials and immediately frozen. Because high concentrations of PrepMan Ultra have been 
shown to be inhibitory (Boyle et al. 2004), we diluted samples 10
-1
 before setting up PCR.  
Post-DNA Extraction (with DNeasy) Solutions 
BSA. BSA solution was prepared at room temperature by the addition of lyophilized BSA 
powder (A4161, Sigma-Aldrich) to DNA-safe water followed by gentle mixing (without 
vortexing, until completely dissolved). This solution was then diluted serially to obtain a final 
concentration of 1000 ng/µl. The final concentration of BSA in the PCR master mix was 400 
ng/µl (10 µl of BSA/25 µl PCR master mix), which was previously shown to be the optimal 
concentration for minimizing PCR inhibition (Kreader et al. 1996, Garland et al. 2010). 
PowerClean DNA Clean-up Kit. The PowerClean procedure was performed according to the 
Experienced User Protocol in the MoBio Instruction Manual (v. 06222010). Starting sample 
volume was 150 µl.  
Inhibitor resistant Taq Polymerase mutants. Several inhibitor resistant Taq polymerases 
(Klentaq LA, Omni Klentaq LA, OmniTaq LA, Cesium Klentaq AC LA, and CesiumTaq LA) 
and their paired reaction buffers developed by DNA Polymerase Technologies were tested for 
their efficiency at replicating Bd DNA in the presence of inhibitors. Testing showed that a 
combination of Omni Klentaq LA and PCR Enhancer-2 produced the best results with the Bd 
primers used, minimizing HA inhibition (results not shown). Therefore only Omni Klentaq LA 
and PCR Enhancer-2 were used for the rest of the comparisons. A detailed description of this 
procedure is outlined below.  
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Verification of Methods 
 The Amplitaq Gold PCR with BSA was tested for its effectiveness at minimizing the 
effects of PCR inhibition using Peruvian amphibian skin swabs that were collected in 2011. The 
results were compared to that of an Amplitaq Gold PCR using the same samples. A subset of 
these samples that were either Bd-positive, Bd-negative, or ambiguous were then purified with 
PowerClean to investigate its effectiveness at removing PCR inhibitors. The results were 
compared to that of Amplitaq Gold PCR with BSA using the same samples. 
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Analysis 
End Point PCR with Amplitaq Gold. An end-point PCR assay previously optimized by Kosch et 
al. (Chapter 3) which utilizes the PCR primers (Bd1a: 5’-CAGTGTGCCATATGTCACG-3’, 
Bd2a: 5’-CATGGTTCATATCTGTCCAG-3’) developed by Annis et al. (2004) was used to 
analyze the effectiveness of the techniques we tested. Briefly, the reaction recipe consisted of: 
2.6 μl of DNA Gold Buffer (10x, ABI), 2.08 μl of MgCl2 (16.7 μM, ABI), 5.0 μl of GeneAmp 
dNTP mix with dTTP (1000 μM, ABI), 1.0 μl of forward and reverse primers (5 μM, 
Invitrogen), 0.125 μl of AmpliTaq Gold with GeneAmp (5 units/μl, ABI), 10.45 μl of DNA 
grade water (Fisher), 2.75 μl of sample for a total reaction volume of 25 μl. The following 
thermal cycler program was utilized on a MultiGene TC9600-G machine (Labnet International): 
1) 5 minutes at 95°C, 2) 45 seconds at 93°C, 3) 45 seconds at 60°C, 4) 1 minute at 72°C, 5) 
repeat steps # 2-4 for 44 more times, and 6) 10 minutes at 72°C. This Bd assay was utilized for 
all methods comparisons unless stated otherwise.  
End Point PCR with Omni Klentaq LA. The reaction recipe and thermal cycler conditions were 
optimized for use with the Bd primers developed by Annis et al. (2004, mentioned above) from 
the DNA Polymerase Technologies (DPT) protocol for mutant Taq polymerases. The reaction 
recipe consisted of: 2.5 µL of 10x Buffer (Klentaq Mutant, DPT), 5.0 μl of GeneAmp dNTP mix 
with dTTP (1000 μM, ABI), 1.0 μl of forward and reverse primers (5 μM, Invitrogen), 0.25 µL 
of Taq polymerase (Omni Klentaq LA; DPT), 12.5 µL of PCR Enhancer Cocktail-2 (PEC-2; 
DPT), and 2.75 μl of sample for a total reaction volume of 25 μl. Thermal cycler conditions were 
as follows: 1) 10 minutes at 94°C, 2) 45 seconds at 94°C, 3) 45 seconds at 60°C, 4) 2 minutes at 
68°C, 5) repeat steps # 2-4 for 44 more times, and 6) 10 minutes at 68°C.  
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Gel electrophoresis. PCR products were separated using gel electrophoresis which allowed us to 
qualitatively compare the effectiveness of each method. This procedure was performed by 
loading 8 µL of PCR product combined with 1 µL of loading dye (6X; Apex) to individual wells 
of an agarose gel (90 ml of 1x TBE Buffer, 1.35 g of agarose, Apex). Additionally, one well per 
row was loaded with 100 bp DNA ladder (Promega), so that the size of the PCR amplicons could 
be estimated. Gels are then immersed in 1x TBE Buffer and 120 volts of current are passed 
through for approximately 40 minutes, after which gels are examined and photographed using a 
UV viewing apparatus.  
Ease of procedure. Ease of procedure was determined by counting the number of steps (e.g., 
pipetting, vortexing, incubation) for each procedure.   
Calculating percent improvement and percent inhibited. In order to evaluate the effect that PCR 
inhibition has on PCR analysis of field samples, we calculated percent improvement and percent 
inhibition using gel electrophoresis results from a subset of our amphibian skin swabs collected 
in Peru in 2011. Percent improvement was calculated as: [(total new positives detected- total 
known positives)/N] x 100%. Percent inhibition was calculated as: (Total lanes without primer 
dimers/N) x 100%.   
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Results 
Preliminary Investigation 
 The absence of 300 bp bands and primer dimers (<50 bp band) from an amphibian skin 
swab spiked with Bd and previously extracted with DNeasy indicate the PCR is being inhibited 
at initial sample concentrations from 1 to 1/100 (Figure 7). Furthermore, a preliminary analysis 
of 94 amphibian skin swabs (by scoring for the presence/absence of primer dimers) indicates that 
PCR inhibition is occurring in 89% of amphibian skin swabs (Table 11). 
DNA Extraction Solutions 
 Of the four DNA extraction methods tested, QIAamp DNA Stool, and PowerLyzer 
PowerSoil were equally effective at removing humic acid from experimental samples (maximum 
capability of 1 µg/µl of HA), DNeasy was the next most effective method (maximum capability 
of 0.1 µg/µl of HA) and PrepMan Ultra was the least effective method (maximum capability of 
0.01 µg/µl of HA, Table 10, Figure 8). Although QIAamp DNA Stool and PowerLyzer 
PowerSoil are better at removing humic acid than DNeasy and PrepMan Ultra, the efficiency of 
these two methods (as indicated by the intensity of the resulting bands during electrophoresis) is 
lower (Figure 8).  
 A cost analysis of DNA extraction techniques showed that PrepMan Ultra was the least 
expensive method to perform with costs varying from $0.27 for PrepMan Ultra, $2.33 for 
DNeasy, $3.84 for QIAamp DNA Stool and $4.36 for PowerLyzer PowerSoil (Table 10).  
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 A comparison of the number of steps per procedure showed that PrepMan Ultra had the 
least number of steps at nine, followed by DNeasy with 20, QIAamp DNA Stool with 32, and 
PowerLyzer PowerSoil with 46 (Table 10).  
Post-DNA Extraction Solutions (with DNeasy) 
 Several different techniques were tested for their effectiveness dealing with HA post-
DNA Extraction. PowerClean is a method that removes inhibitors from extracted DNA template, 
BSA minimizes inhibitory effects when added to the PCR by binding to inhibitory compounds 
(Loomis 1974), and Omni Klentaq LA is a mutant Taq polymerase that was developed to resist 
HA inhibition. Of these methods, PowerClean was the most effective at dealing with high HA 
concentrations in samples (maximum capability of 10 µg/µl of HA, Figure 10), followed by BSA 
combined with Amplitaq Gold (maximum capability of 0.1 µg/µl of HA), and Omni Klentaq LA 
(maximum capability of 0.01 µg/µl of HA, Table 10, Figure 9). All of these methods 
outperformed the original Bd PCR assay with Amplitaq Gold which was inhibited by HA 
concentrations as low as 0.01 µg/µl (Table 10, Figure 9). 
 A cost analysis of post-DNA extraction techniques showed that BSA combined with 
Amplitaq Gold was the least expensive at $0.4193, followed by Omni Klentaq LA at $0.78, and 
PowerClean at $3.32 (Table 10). All of the methods were more expensive than original Bd PCR 
assay with Amplitaq Gold, but the addition of BSA to this reaction can be done for only a 
minimal cost increase of $0.005 per sample (Table 10).  
 The number of steps for each procedure was only analyzed for PowerClean, because the 
increase in the number of steps with Omni Klentaq LA or BSA compared to the original Bd PCR 
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assay with Amplitaq Gold was negligible. However, use of PowerClean does increase the effort 
involved in screening samples for Bd by adding an additional 30 steps (Table 10).  
Verification of Methods 
 The Amplitaq Gold PCR reaction with BSA was tested for its effectiveness at minimizing 
the effects of PCR inhibition using 94 Peruvian amphibian skin swabs that were collected in 
2011 and later extracted with DNeasy. The results of a comparison of a PCR analyses performed 
with and without BSA indicate that four of 94 previously Bd- negative samples were Bd-positive 
demonstrating a 4% improvement in detection ability when using BSA (Table 11, Figure 11). A 
subset of 26 of the previous field samples (three Bd-positive, 11 Bd-negative, or 12 ambiguous) 
were then purified with PowerClean to determine if some samples were still inhibitory. Results 
show that the number of Bd-positive samples increases from three to five after PowerClean 
purification demonstrating an 8% improvement in detection ability when using this method 
(Table 11, Figure 12).  
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Discussion 
 The results of this study and Garland et al. (2010) indicate that PCR inhibition is a 
common occurrence in the Bd assay (i.e., prevalence of 89% and 72.5% respectively). 
Additionally, our results demonstrate that the absence of primer dimer bands can be utilized as a 
preliminary indicator of PCR inhibition (Figure 7). 
 DNA extraction is the first line of defense against PCR inhibitors; therefore, choosing an 
effective method is important, especially when working with amphibian skin swabs which can be 
chemically complex and variable. Here, I demonstrate that QIAamp DNA Stool and PowerLyzer 
PowerSoil are the most effective DNA extraction methods at removing high concentrations of 
humic acid from samples (Figure 8). Additionally, I demonstrate that the previously suggested 
method for Bd sample extraction, PrepMan Ultra (e.g., Hyatt et al. 2007) is ineffective at 
removing humic acid from samples at starting concentrations as low as 0.1 µg/µL (Figure 8). A 
comparison of cost per sample and ease of method shows that PrepMan Ultra is the cheapest and 
easiest method to perform followed by DNeasy, and then QIAamp DNA Stool and PowerLyzer 
PowerSoil (Table 10).  
 Our results show that Amplitaq Gold is highly sensitive to humic acid PCR inhibition 
(minimum inhibitory concentrations of 0.01 µg/µl, Figure 9). Of the methods that we compared 
for minimizing inhibitory effects of humic acid post-DNA extraction, PowerClean was the most 
effective at handling high humic acid concentrations followed by BSA and Omni Klentaq LA 
(Table 10, Figures 9 and 10). Although PowerClean was the most effective method, it was also 
the most expensive and time consuming post-DNA extraction procedure (Table 10).  
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 An applicability test performed using 94 field swabs showed that the addition of BSA to 
the Amplitaq Gold PCR increased the likelihood of detecting Bd by 4% (Table 11). A later test 
with a subset of the previous samples showed that the likelihood of Bd detection was further 
increased by another 4% after sample cleanup with PowerClean (Table 11). Since the samples 
used in these tests are field samples, it is not possible to verify their Bd status; however, when 
combined with the results of our controlled laboratory study, they further validate the 
applicability of this method for screening for the presence of Bd using field swabs containing 
PCR inhibitors.  
 The combined results of this investigation suggest the importance of considering the 
implications of PCR inhibitors in Bd studies. Furthermore, these results indicate that previous Bd 
studies that have not dealt with the potential presence of inhibitors may be drastically 
underestimating the prevalence of this disease by at least as much as 8% (Table 11). Such results 
indicate that consideration needs to be taken when planning and implementing a field study for 
Bd to minimize the likelihood of detecting false negatives from PCR inhibition. Whenever 
possible, researchers should avoid contamination of swabs with soil or leaf litter during 
collection and take special precautions (e.g., use a DNA extraction method designed for HA 
removal such as QIAamp DNA Stool) when handling samples that are thought to contain high 
concentrations of these substances. Secondly, because the use of BSA is very economical, it 
should be added to all Bd PCR assays as an added precaution against PCR inhibition. Lastly, the 
presence/absence of primer dimers should be determined for “negative” samples since the 
absence of this band indicates PCR inhibition. In such cases, PowerClean can be used to remove 
inhibitors before repeating the PCR assay.  
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 The results of this study highlight the vulnerability of the PCR assay to inhibition by 
environmental contaminants, and may have important implications in other fields that use PCR 
for presence/absence studies such as dietary analysis, microbiome studies, and epidemiological 
surveys where such factors may be overlooked.  
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Conclusion 
 Although QIAamp DNA Stool, PowerLyzer PowerSoil are the most effective methods at 
removing humic acid from samples, we recommend using the DNeasy kit instead because it is 
more rapid and economical (Table 10) as well as efficient (Figure 8 and results of previous 
comparison of efficiency of PrepMan Ultra and DNeasy, Chapter 3). DNA extraction efficiency 
is a critical component of the Bd assay, and this especially true when sampling amphibians in the 
initial stages of infection or when sequencing is involved.  Although PowerClean is very 
effective, we recommend that it only be used for samples that are still inhibited even after the 
addition of BSA, as PowerClean is a very costly and time consuming method to perform (Table 
10). For general use, the Bd PCR assay with DNeasy, BSA and Amplitaq Gold is reliable and 
relatively robust to HA inhibition as well as economical and easy to perform in any standard 
molecular lab.  
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Tables and Figures 
Table 10. Comparison of techniques for minimizing the effects of humic acid (HA) for 
Batrachochytrium dendrobatidis (Bd) PCR assay. 
      
Effectiveness (HA concentration µg/µl) 
 
Technique Cost/sample # Steps 10 1 0.1 0.01 0.001 
DNeasy
1
 $ 2.33 20 no no yes yes yes 
Prepman Ultra
1
 $ 0.27* 9* no no no yes yes 
QIAamp DNA Stool 
1
 $ 3.84 32 no yes* yes yes yes 
PowerLyzer PowerSoil 
1
 $ 4.36 46 no yes* yes yes yes 
Amplitaq Gold $ 0.41875* n/a no no no no yes 
Amplitaq Gold and BSA $ 0.41925 n/a no no yes yes yes 
Omni Klentaq LA $ 0.78 n/a no no no yes yes 
PowerClean $ 3.32 30 yes* yes yes yes yes 
1 DNA extraction methods, * best per category 
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Table 11. Comparison of techniques for minimizing the effects of humic acid (HA) in the 
Batrachochytrium dendrobatidis (Bd) PCR assay using Peruvian amphibian field swabs collected 
in 2011 and extracted with DNeasy.  
Technique N Primer Dimers 
Absent  
Bd-
positive  
Percent 
Improvement 
Percent 
Inhibition 
Amplitaq Gold 94 84 0 n/a 89% 
Amplitaq Gold and BSA 94 2 4 4% 2% 
Amplitaq Gold, BSA, and 
PowerClean 
26 0 5 8% 0% 
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Figure 7. Serial dilution of representative inhibitory amphibian skin swab spiked with 
Batrachochytrium dendrobatidis (Bd) for visualization. LD=100bp DNA ladder, PD=primer 
dimer, NC=negative control, PC=positive control. 
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Figure 8. Comparison of the effectiveness of DNA extraction techniques at removing humic acid 
(HA) from Batrachochytrium dendrobatidis (Bd) samples.  
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Figure 9. Comparison of techniques for minimizing the effects of humic acid (HA) from 
Batrachochytrium dendrobatidis (Bd) samples post-DNA extraction.  
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Figure 10. Comparison of the effectiveness of PowerClean at removing humic acid (HA) from 
Batrachochytrium dendrobatidis (Bd) samples. 
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Figure 11. Representative gel images for the verification of the effectiveness of Amplitaq Gold 
PCR with BSA at minimizing the effects of PCR inhibitors using field samples extracted with 
DNeasy. A) PCR with Amplitaq Gold, B) PCR with Amplitaq Gold and BSA. LD=100bp DNA 
ladder, PD=primer dimer, NC=negative control, PC=positive control, + Bd positive, - Bd 
negative, ? ambiguous.   
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Figure 12. Representative gel images for the verification of the effectiveness of PowerClean at 
removing PCR inhibitors from field samples extracted with DNeasy. A) PCR with Amplitaq 
Gold and BSA, B) PCR with Amplitaq Gold and BSA using samples purified with Powerclean. 
LD=100bp DNA ladder, PD=primer dimer, NC=negative control, PC=positive control, + Bd 
positive, - Bd negative, ? ambiguous.  
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CHAPTER 5: GENERAL OVERVIEW AND BROADER IMPACTS 
Bd in Peru 
 In Chapter 2, I discuss the results of my sampling effort from the dry seasons of 2007 and 
2008 showed that Bd is widely distributed throughout Peru, with among site prevalence ranging 
from 0 to 25%. Bd was detected in 11 of 983 individuals sampled, and in 9 out of 38 sites 
ranging in altitude from 96-3240 meters. We detected Bd in 11 species of anurans belonging to 
14 families. The family with the highest number of Bd-positive individuals was Hylidae with 
four positive samples, all from different species. The disease also was detected in one of two 
Telmatobius marmoratus purchased at a market in Cusco where they were being sold for human 
consumption further supporting the idea that human transport of amphibians is facilitating the 
dispersal of this Bd. We strongly recommend further studies of Bd in Peru in order to better 
understand the ecology of this devastating disease and its effects on this biodiverse region. 
Although the results of this and previous studies demonstrate that Bd is widespread in South 
America (e.g., Brazil: Carnaval et al. 2006, Venezuela: Sánchez et al. 2008, Argentina: 
Barrionuevo and Ponssa 2008), the consequences of this disease are still relatively unknown due 
to the near complete absence of general population monitoring and Bd studies in these countries. 
In Peru, significant declines have been reported in multiple high-elevation species in southern 
Peru (Catenazzi et al. 2011), and several Atelopus and Telmatobius species are believed to 
already be extinct (Venegas et al. 2008, von May et al. 2008). Peru contains some of the highest 
amphibian diversity on record and the loss of this diversity could have severe consequences. This 
makes the lack of knowledge on Bd and population status of Peru’s amphibians especially 
alarming.  
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In the discussion section of Chapter 2, I make brief mention of a theoretical model for estimating 
disease prevalence proposed by Cannon and Roe (1982). The authors stated that at least 30 
individuals need to be swabbed per locality in order to detect at least one positive individual at a 
site if the disease prevalence is 10% (Cannon and Roe 1982). I reasoned that if Cannon and 
Roe’s model holds true, I may have underestimated the actual Bd prevalence in localities where I 
was unable to collect at least 30 individuals. One potential caveat with Cannon and Roe’s model 
is that population disease history and/or environmental conditions may influence the researcher’s 
ability to accurately approximate disease prevalence. For example, in a population with a long 
history of Bd and/or environmental conditions non-conducive to promoting pathogenicity (e.g., a 
lowland population), Bd prevalence may be high, but mortality will be low, reflecting long term 
coevolution between pathogen and host and/or as a suboptimal environmental regime for the 
pathogen. Conversely, if sampling is performed in a population with a recent introduction of Bd 
and/or optimal environmental conditions for the pathogen (e.g., a highland population), Bd 
prevalence may be skewed. This is especially true if host population size is small and/or 
heterogeneously distributed, which may contribute to “pockets” of high disease prevalence 
distributed among regions that are relatively disease free (i.e., due to lack of disease 
transmission). Such information can be deceiving because it does not provide valuable insight 
about the disease threat of the population. In fact, high disease prevalence such as what would be 
detected in example 1, would actually give the false impression that disease severity (i.e., 
population threat) is worse than it actually is. Conversely, as in the second example, if one were 
not careful about their sampling design, they may not detect the disease at all or may report 
prevalences lower than they are in actuality (especially if they do not sample individuals from 
infection pockets). Both of the above scenarios illustrate the importance of conducting Bd 
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surveys along large transects in order to capture heterogeneity of disease prevalence within 
populations. They also illustrate the value of long term studies to accurately monitor host 
abundance and infection dynamics (especially if the pathogen is truly novel). Such strategies will 
provide more valuable information about Bd population effects than disease “snapshot” 
prevalence studies can alone. Additionally, they can provide more accurate estimates of 
population disease prevalence in dynamic and/or heterogeneous host populations.  
I mention this here because I would like to emphasize that although I may not have sampled 30 
individuals from every population, my sampling scheme was designed in order to minimize some 
of the potential problems mentioned above (e.g., many populations were sampled from the same 
environmental conditions, sampling procedure consisted of long transects). Finally, even though 
I believe that this study made a valuable contribution to science, by being the first to 
systematically investigate Bd prevalence across Peru, such an investigation is only providing a 
glimpse of what is actually going on with Bd in Peru; and the only way to actually understand the 
true effects of this disease in Peru is to implement long term studies.  
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Techniques for Detecting Bd 
 Since the discovery of Bd in 1998, several methods have been used for detection; among 
these PCR from skin swabs is accepted as the best method due to its high sensitivity, non-
invasiveness and ease of use. However, since PCR is a chemical reaction that requires a specific 
DNA template to proceed, this method relies upon the presence of non-degraded DNA template. 
The methods discussed in Chapter 3 were developed with the hopes that they would increase the 
number of Bd studies being performed in developing countries or by researchers from smaller 
labs, which may not be able to afford qPCR equipment and reagents. I showed that the end-point 
PCR assay using Amplitaq Gold (ABI) that I developed is equally sensitive to the conventional 
Bd qPCR assay. I argued that in addition to the being cost prohibitive, the Bd qPCR assay has the 
added disadvantage of reduced specificity in comparison to end-point PCR. Lastly, I explained 
that the reduction in the specificity of qPCR is an inherent characteristic of this test that is driven 
by the occurrence of background fluorescence, which makes definitive scoring of 
presence/absence of Bd a subjective process.   
 I also tested two widely used methods for DNA extraction (DNeasy, Qiagen and 
PrepMan Ultra, ABI) and three methods for sample preservation (dry, 95% ethanol, and DMSO). 
My results showed that despite the extra cost and time commitment of performing the DNeasy 
technique, it outperforms PrepMan Ultra in both extraction efficiency and reliability. 
Additionally, I discussed the pros and cons of the three preservation methods that I tested and 
suggest that although all three the methods worked similarly well, the 95% ethanol method 
should be used for field studies since it has a lower risk of failure (i.e., because it eliminates the 
possibility of growth from microbial contaminants).   
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  This study is the first to compare the many of the published methods for Bd sample 
preservation, extraction, and detection.  I believe that the results of this study will benefit Bd 
research by providing a reliable and cost effective means of performing Bd research in smaller, 
less financially stable labs. 
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Minimizing PCR Inhibition 
 The occurrence PCR inhibition in Bd studies is frequently overlooked despite reports that 
it can occur in up to 25% and 72.5 % of samples (Hyatt et al. 2007, Garland et al. 2010 
respectively). Reports of such high incidences of PCR inhibition suggest that researchers who do 
not nullify the effects of PCR inhibitors may be drastically underestimating Bd prevalence. 
  In Chapter 4, I showed that PCR inhibition affected at least 89% of samples tested, and 
proposed that the main cause of PCR inhibition in the Bd assay may be humic acid, a known 
inhibitor of Taq polymerase. I tested the effectiveness of eight techniques developed by 
researchers working with soil and fecal samples for dealing with humic acid inhibition. Four of 
techniques tested can be used for DNA extraction: DNeasy (Qiagen), QIAamp DNA Stool 
(Qiagen), PowerLyzer PowerSoil (MoBio), and PrepMan Ultra (ABI); and four techniques were 
developed for analyzing Bd samples post-DNA extraction: Amplitaq Gold (ABI), Bovine Serum 
Albumin (BSA, Sigma Aldrich), PowerClean DNA Clean-up Kit (MoBio), and inhibitor resistant 
Taq Polymerase mutants (DNA Polymerase Technologies).  
 All of the techniques tested were fairly good at removing humic acids,  with the 
exception of PrepMan Ultra, which was only capable of  removing 0.01 µg/µl of humic acid 
from the samples (interestingly this is the most widely used extraction method in Bd studies, of 
42 studies analyzed, 88% used PrepMan Ultra, author unpublished). Because the techniques 
varied in effectiveness, I discussed the pros and cons of each method and conclude by 
recommending the use of the DNeasy kit for DNA extraction, and the end-point PCR assay with 
Amplitaq Gold and BSA due their effectiveness at removing humic acids, low cost, and relative 
ease of use. Additionally, although I found that PowerClean was very effective at removing 
humic acids, I recommend that it only be used for samples that are still inhibitory even after the 
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addition of BSA, as PowerClean is a very costly and time consuming method to perform. Lastly, 
I verified the use of these methods using real skin swabs collected in Peru in 2011. The addition 
of BSA to the end-point PCR with Amplitaq Gold improved detection capability by 4%, and 
showed that detection capability can be further increased by 8% when purifying samples with 
PowerClean and repeating the PCR. The dramatic increases in Bd detection capability observed 
when using BSA and/or PowerClean highlight the major consequences that humic acid 
contamination can have on Bd PCR assay results. These results indicate that studies that do not 
address humic acid contamination when performing DNA extraction and PCR analyses may be 
dramatically underestimating Bd prevalence.  
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Highlights and Broader Impacts  
 In this document I have emphasized the importance of investigating chytridiomycosis, 
and stressed the importance of conducting studies of this disease in undeveloped countries. I 
have also discussed the value of continued surveillance of amphibian populations and discussed 
some management strategies for Bd. The results of my investigation of the prevalence of Bd in 
Peru demonstrate that the disease is widespread throughout Peru. My discovery of a Bd-positive 
Telmatobius marmoratus at a market in Cusco provides further support to the developing 
hypothesis that amphibian trade may be abetting the global spread of Bd. Lastly, I have 
developed and verified the efficacy of several methods for sample preservation, DNA extraction, 
PCR testing, and reduction of PCR inhibition, which greatly improve applicability of performing 
Bd assays in smaller labs or in developing countries. 
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APPENDIX A 
Table A. Major supplies companies used for techniques discussed in this document. 
 
 
 
 
 
 
 
 
Company City State 
Applied Biosystems (ABI) Foster City CA 
BioSpec Products Bartlesville OK 
DNA Polymerase Technology, Inc. St. Louis MO 
Fisher Scientific Pittsburg PA 
Gene Tools Philomath OR 
Genesee San Diego CA 
Invitrogen Grand Island NY 
Medical Wire and Equipment Durham NC 
MoBio Carlsbad CA 
Pisces Molecular Boulder CO 
Promega Madison WI 
Qiagen Valencia CA 
Sigma-Aldrich St. Louis MO 
USB Products Cleveland OH 
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Table B. Major supplies used for techniques compared in Chapter 3. 
Product Company Product # Amount Cost 
Chytr51 MGB TaqMan Probe Applied 
Biosystems 
4316034 6,000 
pmoles 
$255 
PrepMan Ultra Applied 
Biosystems 
4318930 20 ml $108 
GeneAmp® dNTP Blend, 10mM Applied 
Biosystems 
N8080260 1 ml $50 
AmpliTaq Gold  w/ Buffer and MgCl2 Applied 
Biosystems 
4311816 1000 
units 
$670 
GeneAmp® dNTP Blend, 10mM Applied 
Biosystems 
N8080260 1 ml $50 
MicroAmp® Optical 96-Well Reaction 
Plate 
Applied 
Biosystems 
N8010560 10 plates $114 
TaqMan® Exogenous Internal Positive 
Control Reagent 
Applied 
Biosystems 
4308323 
 
200 rnx $230 
Zirconium/silica beads (0.5mm diameter) 
 
BioSpec 
Products 
11079105z 454 g $47 
Mini Beadbeater 1 
 
BioSpec 
Products 
3110BX 1 unit $842 
Optical Adhesive Covers Applied 
Biosystems 
4360954 25 $62 
7500 Fast Real-Time PCR System Applied 
Biosystems 
4359286 1 $49,000 
Polypropylene Microvials (for Beadbeater) 
 
BioSpec 
Products 
522S 500 
count 
$134 
Sterile Dry Swabs 
 
Medical Wire 
& Eq. 
MW113 1250 
swabs 
$298 
100 bp DNA ladder 
 
Promega PR-G2101 250 μl $112 
DNeasy Kit  
 
Qiagen 69506 250 
samples 
$583 
AlumSeal II Films 
 
Genesee 12-169 100 $85 
96-well PRC Plates 
 
Genesee 24-300 25 $107 
Peltier PTC-200 Thermal Cycler 
 
Gene Tools PTC-200 1 $3,800 
ExoSAP-IT  
 
USB 78200 200 μl $96 
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Table C. Major supplies used for techniques compared in Chapter 4.  
Product Company Product # Amount Cost 
PrepMan Ultra Applied 
Biosystems 
4318930 20 ml $108 
GeneAmp® dNTP Blend, 10mM Applied 
Biosystems 
N8080260 1 ml $50 
AmpliTaq Gold  w/ Buffer and MgCl2 Applied 
Biosystems 
4311816 1000 units $670 
Zirconium/silica beads (0.5mm 
diameter) 
BioSpec Products 11079105z 454 g $47 
Mini Beadbeater 1 BioSpec Products 3110BX 1 unit $842 
Sterile Dry Swabs Medical Wire & 
Eq. 
MW113 1250 swabs $298 
100 bp DNA ladder Promega PR-G2101 250 μl $112 
DNeasy Kit  Qiagen 69506 250 
samples 
$583 
QIAamp DNA Stool  Qiagen 51504 50 preps $192 
PowerLyzer PowerSoil  MoBio 12855-50 50 preps $218 
PowerClean DNA  MoBio 12877-50 50 preps $166 
Humic Acid Sigma-Aldrich 53680 10 g $40 
Bovine Serum Albumin (BSA) Sigma-Aldrich A4161 250 mg $33 
Omni Klentaq LA DNA Poly. Tech 350 125 μl $270 
PCR Enhancer Cocktail-2 DNA Poly. Tech E620 6,250 μl $120 
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APPENDIX B 
IACUC Approval Letters 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Animal Care and Use Committee
East Carol ina Univers i ty
212F:d Warren Li fe Scicnces Bui ld ing
Greenvi l le,  NC 2i834
252-744.2436 office . 252.744.2355 fax
E A S T
CAROLINA
UIIIVERSITY
-
December 18, 2008
Kyle Summers, Ph.D.
Department of Biology
Howell Science Complex
East Carolina Universitv
Dear Dr. Summers:
Your Animal Use Protocol entitled, "Chytridiomycosis n Peru," (AUP #D229) was reviewed by
this institution's Animal Care and Use Committee on December 16,2008. The following action
was taken by the Committee:
"Approved at submitted"
As a note, the pending NSF grant has not been submitted to the IACUC for review.
Please contact me if I can be of further assistance.
Sincerely yours,
Robert G. Carroll, Ph.D.
Chairman, Animal Care and Use Committee
RGC/jd
enclosure
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